<?xml version="1.0"?>
<tei xml:space="preserve">
	<teiHeader>
		<fileDesc xml:id="0"/>
	</teiHeader>
	<text xml:lang="en">
			<front>Molecules 2010, 15, 2269-2301; doi:10.3390/molecules15042269 <lb/>molecules <lb/>ISSN 1420-3049 <lb/>www.mdpi.com/journal/molecules <lb/>Article <lb/>Synthesis of Dihydrouracils Spiro-Fused to Pyrrolidines: <lb/>Druglike Molecules Based on the 2-Arylethyl Amine Scaffold <lb/>Daniel Blanco-Ania 1 , Carolina Valderas-Cortina 1 , Pedro H.H. Hermkens 2 , Leo A.J.M. <lb/>Sliedregt 3 , Hans W. Scheeren 1 and Floris P.J.T. Rutjes 1, * <lb/>1 Institute for Molecules and Materials, Radboud University Nijmegen, Heyendaalseweg 135, 6525 <lb/>AJ Nijmegen, The Netherlands <lb/>2 MSD Research Laboratories, P.O. Box 20, 5340 BH Oss, The Netherlands <lb/>3 Solvay Pharmaceuticals, Sector Discovery Weesp, P.O. Box 900, 1380 DA Weesp, The <lb/>Netherlands <lb/> * Author to whom correspondence should be addressed; E-Mail: f.rutjes@science.ru.nl. <lb/>Received: 5 February 2010; in revised form: 26 March 2010 / Accepted: 30 March 2010 / <lb/>Published: 30 March 2010 <lb/>Abstract: The synthesis of a small library of dihydrouracils spiro-fused to pyrrolidines is <lb/>described. These compounds are synthesized from β-aryl pyrrolidines, providing products <lb/>with the 2-arylethyl amine moiety, a structural feature often encountered in compounds <lb/>active in the central nervous system. The β-aryl pyrrolidines are synthesized through a <lb/>three-step methodology that includes a Knoevenagel condensation reaction, a 1,3-dipolar <lb/>cycloaddition reaction, and a nitrile reduction. <lb/>Keywords: Knoevenagel condensation; 1,3-dipolar cycloaddition; azomethine ylide; <lb/>parallel synthesis; spiro dihydrouracils <lb/></front>

			<body>1. Introduction <lb/>The 2-arylethyl amine moiety 1 (Figure 1) is an important privileged structure, which is <lb/>encountered in numerous compounds active in the central nervous system (CNS). This privileged <lb/>structure is present in neurotransmitters such as dopamine, epinephrine, norepinephrine, and serotonin <lb/>[1]. Salmeterol [2,3] and venlafaxine [4-6], two of the ten best-selling prescription drugs in 2006 [7], <lb/>OPEN ACCESS <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2270 <lb/></page>

			<body>also contain this moiety. In addition, the 2-arylethyl amine unit occurs in many hallucinogenic drugs, <lb/>such as LSD, MDMA (ecstasy), mescaline, and psilocybin (magic mushrooms) [8,9]. <lb/>Figure 1. 2-Arylethyl amine (1), uracil (2), thymine (3), and zidovudine (AZT, 4). <lb/>2 <lb/>NH <lb/>H <lb/>N <lb/>O <lb/>O <lb/>3 <lb/>NH <lb/>H <lb/>N <lb/>O <lb/>O <lb/>Me <lb/>4 <lb/>N <lb/>H <lb/>N <lb/>O <lb/>O <lb/>Me <lb/>O <lb/>N 3 <lb/>HO <lb/>Ar <lb/>NH 2 <lb/>1 <lb/>On the other hand, pyrimidine-2,4-diones are a class of bioactive heterocyclic molecules, the most <lb/>famous examples being uracil (2) and thymine (3, Figure 1), which form part of the nucleotides of <lb/>RNA and DNA, respectively [10]. Pyrimidine-2,4-diones have attracted considerable attention in the <lb/>pharmaceutical industry as anti-inflammatory agents [11], dopamine receptor agonists [12], serotonin <lb/>uptake inhibitors [13], and antiepileptic agents [14]. A good example of a pyrimidine-2,4-dione <lb/>derivative with a medicinal application is zidovudine (AZT, 4, Figure 1), used as an anti-AIDS agent <lb/>[15]. This moiety is also the core structural element of some fungicides [16] and herbicides [17]. <lb/>It is known that the difference in activity and receptor selectivity of drugs might be explained by the <lb/>conformation of the contained privileged structure. Generation of semi-rigid drugs facilitates the study <lb/>of their interactions with the receptors, may lead to more selective interactions with fewer side effects, <lb/>and permits the rational design of more potent and selective drugs in the future [18,19]. Herein we <lb/>present the parallel synthesis of a library comprised of compounds combining all the above features <lb/>(Scheme 1). First, these compounds possess a β-aryl pyrrolidine with a conformationally constrained <lb/>2-arylethyl amine. Second, they are semirigid structures because of the spiro fusion to a dihydrouracil. <lb/>It is known that the combination of privileged structures can lead to new chemical entities that may <lb/>have pharmacological relevance [20,21] and increase the structural diversity. <lb/>Scheme 1. Combination of two privileged structures to generate a product with increased rigidity. <lb/>1 + 2 <lb/>HN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>R <lb/>Ar <lb/>possible new <lb/>biological activity <lb/>2. Results and Discussion <lb/>We envisioned that a suitable strategy to synthesize these compounds may proceed as shown <lb/>retrosynthetically in Scheme 2. The spiro dihydrouracils 5 could be synthesized by an annulation <lb/>reaction of α-aminomethyl esters 6 and an isocyanate. The aminomethyl group of compounds 6 could <lb/>be derived from a masked amino function, such as a cyano group, by reduction. Compounds 7 possess <lb/>two electron-withdrawing groups at the carbon in the 3-position of the pyrrolidine, rendering it a <lb/>perfect pattern for preparation by a 1,3-cycloaddition reaction of an azomethine ylide and an electron-<lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2271 <lb/></page>

			<body>deficient alkene. This would leave the 3-aryl-2-cyanoacrylates 8 as starting materials, which could be <lb/>obtained by the Knoevenagel condensation reaction of methyl 2-cyanoacetate (9) and an aromatic <lb/>aldehyde. <lb/>Scheme 2. Retrosynthetic analysis for the synthesis of spiro dihydrouracils 5. <lb/>MeN <lb/>CO 2 Me <lb/>NH 2 <lb/>6 <lb/>MeN <lb/>CO 2 Me <lb/>CN <lb/>7 <lb/>NC <lb/>CO 2 Me <lb/>Ar <lb/>NC <lb/>CO 2 Me <lb/>8 <lb/>9 <lb/>5 <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>R <lb/>Ar <lb/>Ar <lb/>Ar <lb/>2.1. Knoevenagel condensation reaction <lb/>The synthesis of compound class 5 commenced with the condensation reaction of methyl 2-<lb/>cyanoacetate (9) and aromatic aldehydes 10. Twelve aldehydes 10{1-12} (electron-rich aromatic, <lb/>electron-rich heteroaromatic, and electron-poor heteroaromatic aldehydes; Figure 2) were selected for <lb/>the formation of the scaffolds. <lb/>Figure 2. Aromatic aldehydes 10{1-12} used for the Knoevenagel reaction. <lb/>1 <lb/>2 <lb/>3 <lb/>4 <lb/>6 <lb/>5 <lb/>CHO <lb/>CHO <lb/>CHO <lb/>CHO <lb/>N <lb/>Me <lb/>N <lb/>Me <lb/>CHO <lb/>CHO <lb/>N <lb/>H <lb/>N <lb/>H <lb/>CHO <lb/>CHO <lb/>S <lb/>CHO <lb/>N <lb/>CHO <lb/>N <lb/>CHO <lb/>N <lb/>CHO <lb/>MeO <lb/>MeO <lb/>OMe <lb/>O <lb/>O <lb/>7 <lb/>8 <lb/>9 <lb/>10 <lb/>12 <lb/>11 <lb/>The reaction conditions for the Knoevenagel condensation reaction are critically dependent on the <lb/>electron-withdrawing groups bound to the activated methylene [22] and need to be optimized in every <lb/>case. Initially, these reactions were performed using EtOH as solvent, but transesterification (up to <lb/>3%) was observed and the resulting mixture of methyl and ethyl esters was impossible to separate. <lb/>These reactions also took place in THF (see entry 8, Table 1), but required a longer reaction time. <lb/>Finally, treatment of 9 with a catalytic amount of piperidine in MeOH (except for entry 8 because of <lb/>the low solubility of 10{8} in MeOH) at room temperature produced the desired acrylates 8{1-12} in <lb/>excellent yields (Table 1). All these compounds are only sparingly soluble in MeOH, allowing the pure <lb/>crystalline products to be easily collected by filtration. These products can also be recrystallized from <lb/>MeOH yielding crystals of &gt;99.5% purity. The reaction was completely stereoselective in all cases <lb/>[23], only the E alkenes were observed as could be inferred from the 13 C-NMR coupling constants <lb/>between the olefinic proton and the carbon atoms of the ester and the nitrile [24,25]. These values are <lb/>3 J = 6.6-6.9 Hz for the carbonyl group and 3 J = 13.6-13.9 Hz for the cyano group. The Knoevenagel <lb/>adducts are stable at room temperature and unreactive towards the regular atmosphere, therefore <lb/>remain unchanged for months. <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2272 <lb/></page>

			<body>Table 1. Knoevenagel condensation reaction to form the 2-cyanoacrylates 8{1-12}. <lb/>10{1-12}, piperidine <lb/>MeOH, 21 <lb/>°C <lb/>8{1-12} <lb/>NC <lb/>CO 2 Me <lb/>NC <lb/>CO 2 Me <lb/>Ar <lb/>9 <lb/>ArCHO <lb/>Entry ArCHO Product <lb/>Time <lb/>(min) <lb/>Yield <lb/>(%) <lb/>1 <lb/>10{1} <lb/></body>

			<div type="toc">8{1} <lb/>30 <lb/>99 <lb/>2 <lb/>10{2} <lb/>8{2} <lb/>30 <lb/>94 <lb/>3 <lb/>10{3} <lb/>8{3} <lb/>40 <lb/>99 <lb/>4 <lb/>10{4} <lb/>8{4} <lb/>60 <lb/>99 <lb/>5 <lb/>10{5} <lb/>8{5} <lb/>120 <lb/>95 <lb/>6 <lb/>10{6} <lb/>8{6} <lb/>120 <lb/>96 <lb/>7 <lb/>10{7} <lb/>8{7} <lb/>30 <lb/>99 <lb/>8 <lb/>10{8} <lb/>8{8} <lb/>480 a <lb/>99 <lb/>9 <lb/>10{9} <lb/>8{9} <lb/>30 <lb/>94 <lb/>10 <lb/>10{10} <lb/>8{10} <lb/>30 <lb/>99 <lb/>11 <lb/>10{11} <lb/>8{11} <lb/>90 <lb/>93 <lb/>12 <lb/>10{12} <lb/>8{12} <lb/>25 <lb/>99 <lb/></div>

			<body>a THF was used as solvent. <lb/>2.2. 1,3-Dipolar cycloaddition reaction <lb/>The next step in the synthesis was the formation of the pyrrolidine-core structures by a 1,3-dipolar <lb/>cycloaddition reaction using an azomethine ylide. This reaction is an important method for the <lb/>formation of pyrrolidines [26] and has been used in the synthesis of natural products [27,28]. Among <lb/>the vast number of procedures for making azomethine ylides [29-41], the decarboxylative <lb/>condensation of α-amino acids with aldehydes, typically heated in toluene or DMF, was chosen [42]. <lb/>Thus, the reaction of paraformaldehyde and sarcosine (N-methylglycine) in refluxing toluene in the <lb/>presence of the 2-cyanoacrylates 8 cleanly provided the desired pyrrolidines 7, containing the 2-<lb/>arylethyl amine motif (Table 2). The reaction was clean to such an extent that in some cases an <lb/>extraction (H 2 O/Et 2 O) was all the purification needed (or just a short column chromatography). The <lb/>reaction was totally stereospecific in most cases (entries 1-6 and 8), highly stereospecific for 8{9} <lb/>(entry 9), and partially stereospecific for the electron-poor heteroaryls 8{10-12} (entries 10-12) [43]. <lb/>The mixtures of diastereoisomers that arose could not be separated by column chromatography. The <lb/>reaction did not take place with compound 8{7} (entry 7); after 4 h only some minor unidentified <lb/>compounds were formed and most of the substrate was recovered, but there was no trace of compound <lb/>7{7}. The reaction of substrate 8{5} did form the product 7{5}, but with a lower yield compared to all <lb/>the others. The reaction of substrate 8{8} formed the expected cycloadduct, but the indolic nitrogen <lb/>was (dimethylamino)methylated during the reaction. <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2273 <lb/></page>

			<body>Table 2. 1,3-Dipolar cycloaddition reaction to form the pyrrolidine-core structures 7. <lb/>MeNHCH 2 CO 2 H <lb/>(CH 2 O) n , PhMe, Δ <lb/>MeN <lb/>CO 2 Me <lb/>CN <lb/>Ar <lb/>7{1-6,9-13} <lb/>8{1-12} <lb/>NC <lb/>CO 2 Me <lb/>Ar <lb/>Entry <lb/>Acrylate <lb/>Product(s) a <lb/>Time <lb/>(min) <lb/>Yield <lb/>(%) <lb/>1 <lb/>8{1} <lb/>7 {1} <lb/>20 <lb/>94 <lb/>2 <lb/>8{2} <lb/>7 {2} <lb/>75 <lb/>99 <lb/>3 <lb/>8{3} <lb/>7 {3} <lb/>80 <lb/>95 <lb/>4 <lb/>8{4} <lb/>7 {4} <lb/>80 <lb/>99 <lb/>5 <lb/>8{5} <lb/>7 {5} <lb/>120 <lb/>52 <lb/>6 <lb/>8{6} <lb/>7 {6} <lb/>80 <lb/>95 <lb/>7 <lb/>8{7} <lb/>7 {7} <lb/>240 <lb/>-<lb/>8 <lb/>8{8} <lb/>MeN <lb/>CO 2 Me <lb/>CN <lb/>N <lb/>NMe 2 <lb/>7{13} <lb/>150 <lb/>85 <lb/>9 <lb/>8{9} <lb/>7{9} + <lb/>MeN <lb/>CO 2 Me <lb/>CN <lb/>S <lb/>11{9} <lb/>80 <lb/>87 b <lb/>10 <lb/>8{10} <lb/>7{10} <lb/>+ <lb/>MeN <lb/>CO 2 Me <lb/>CN <lb/>N <lb/>11{10} <lb/>45 <lb/>90 c <lb/>11 <lb/>8{11} <lb/>7{11} <lb/>+ <lb/>MeN <lb/>CO 2 Me <lb/>CN <lb/>N <lb/>11{11} <lb/>25 <lb/>72 d <lb/>12 <lb/>8{12} <lb/>7{12} <lb/>+ <lb/>MeN <lb/>CO 2 Me <lb/>CN <lb/>N <lb/>11{12} <lb/>45 <lb/>85 e <lb/>a Ratio calculated by integration of the 1 H-NMR signals of the crude reaction mixture; <lb/>b 7{9}/11{9} = 70:1; c 7{10}/11{10} = 6.5:1; d 7{11}/11{11} = 6.6:1; e 7{12}/11{12} = 5:1 <lb/>After analysis of the results obtained so far, it was decided to continue the research only with the <lb/>diastereomerically pure compounds 7{1-6} for the construction of the library scaffolds. <lb/>2.3. Reduction <lb/>The chemoselective reduction of the nitrile was best achieved by a heterogeneous catalytic <lb/>hydrogenation using Raney nickel under a hydrogen atmosphere at room temperature (Table 3) [44]. <lb/>We found that the addition of NH 3 or Et 3 N was crucial for the reaction to go to completion [45]. <lb/>Eventually, Et 3 N was used since with NH 3 amide 12 (Figure 3) was formed alongside the product. <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2274 <lb/></page>

			<body>Figure 3. Amide 12 formed. <lb/>MeN <lb/>CONH 2 <lb/>CN <lb/>Ar <lb/>12 <lb/>Thus, compounds 7{1-6} were reacted under these conditions to complete the synthesis of the <lb/>library scaffolds. After elimination of Raney nickel by filtration through diatomaceous earth and <lb/>evaporation of MeOH and Et 3 N, the reaction cleanly gave the α-aminomethyl esters 6{1-6}. <lb/>Table 3. Reduction of the cyano group from the α-cyano esters 7. <lb/>MeN <lb/>CO 2 Me <lb/>NH 2 <lb/>MeN <lb/>CO 2 Me <lb/>CN <lb/>Ar <lb/>H 2 , Ra-Ni, Et 3 N <lb/>MeOH, 21 °C, 15 h <lb/>Ar <lb/></body>

			<div type="toc">7{1-6} <lb/>6{1-6} <lb/>Entry Substrate <lb/>Product <lb/>Yield (%) <lb/>1 <lb/>7{1} <lb/>6{1} <lb/>95 <lb/>2 <lb/>7{2} <lb/>6{2} <lb/>95 <lb/>3 <lb/>7{3} <lb/>6{3} <lb/>89 <lb/>4 <lb/>7{4} <lb/>6{4} <lb/>85 <lb/>5 <lb/>7{5} <lb/>6{5} <lb/>73 <lb/>6 <lb/>7{6} <lb/>6{6} <lb/>95 <lb/></div>

			<body>2.4. Parallel synthesis of spiro dihydrouracils <lb/>The procedure followed for the formation of the spiro dihydrouracils was formation of a urea by <lb/>addition of an isocyanate and subsequent cyclization by reaction with a base. The conversion of <lb/>chemset 6 into chemset 5 was accomplished using reagent chemset 13. Eight isocyanates 13{1-8} <lb/>(alkyl, electron-rich aryl, electron-poor aryl, and heteroaryl isocyanates; Figure 4) were selected for <lb/>the generation of a 48-compound library. <lb/>Figure 4. Isocyanates 13{1-8} used for the reaction of scaffolds 6{1-6}. <lb/>NCO <lb/>NCO <lb/>Ph <lb/>NCO <lb/>EtO 2 C <lb/>NCO <lb/>NCO <lb/>NCO <lb/>NCO <lb/>NCO <lb/>N <lb/>F 3 C <lb/>EtO <lb/>NC <lb/>1 <lb/>2 <lb/>3 <lb/>4 <lb/>8 <lb/>7 <lb/>6 <lb/>5 <lb/>The reactions for the formation of the α-ureidomethyl esters were run in either CH 2 Cl 2 or DMF <lb/>depending on reagent solubility and reactivity. Thus, the reactions of 6{1-6} and 13{1,3-5} in CH 2 Cl 2 <lb/>for 15 h at room temperature afforded the corresponding α-ureidomethyl esters. In order to reach full <lb/>conversion to the α-ureidomethyl esters using isocyanates 13{2,6-8}, DMF at 80 °C for 15 h had to be <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2275 <lb/></page>

			<body>used. After evaporation of the solvent, the crude mixture was dissolved in THF and 1 M KOBu t in <lb/>THF (1 equiv) was added [46,47]. The reactions were stirred at room temperature for 15 h and the <lb/>solvent was evaporated. Liquid-liquid extraction afforded two different types of compounds, <lb/>depending on the isocyanate used: (1) the alkyl isocyanates 13{1-3} gave the expected 4-aryl-<lb/>spiro[dihydrouracil-5,3′-pyrrolidines] 5{1-6,1-3} with yields ranging from 49 to 80% (61% average) <lb/>and with purities ranging from 60 to 99% (83% average; Scheme 3 and Table 4) according to LC-MS <lb/>analysis (also confirmed by 1 H-NMR spectroscopy) and (2) the aryl isocyanates 13{4-8} gave mostly <lb/>the unexpected α-ureidomethyl acids 14{1-6,4-8} with yields ranging from 45 to 79% (64% average) <lb/>and with purities ranging from 0 to &gt;99% (82% average; Scheme 4 and Table 5) according to LC-MS <lb/>analysis (also confirmed by 1 H-NMR spectroscopy). <lb/>Scheme 3. Spiro dihydrouracil formation from scaffolds 6{1-6}. <lb/>MeN <lb/>CO 2 Me <lb/>NH 2 <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>R <lb/>Ar <lb/>Ar <lb/>1. RNCO 13{1,3}, CH 2 Cl 2 <lb/>21 °C, 15 h or <lb/>6{1-6} <lb/>R = Et, PhCH 2 CH 2, EtO 2 CCH 2 CH 2 <lb/>2. KOBu t , THF, 21 °C, 15 h <lb/>RNCO 13{2}, DMF <lb/>80 °C, 15 h <lb/>5{1-6,1-3} <lb/>Scheme 4. α-Ureidomethyl acid formation from scaffolds 6{1-6}. <lb/>MeN <lb/>CO 2 Me <lb/>NH 2 <lb/>MeN <lb/>CO 2 H <lb/>Ar <lb/>Ar <lb/>1. RNCO 13{4,5}, CH 2 Cl 2 <lb/>21 °C, 15 h or <lb/>6{1-6} <lb/>2. KOBu t , THF, 21 °C, 15 h <lb/>RNCO 13{6-8}, DMF <lb/>80 °C, 15 h <lb/>R = Ph, 4-CF 3 C 6 H 4 , 4-EtOC 6 H 4 , 3-NCC 6 H 4 , 3-Py <lb/>14{1-6,4-8} <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>R <lb/>The reactions carried out with reagent 13{1} resulted in high purities (89% average) for the <lb/>formation of the spiro dihydrouracils, due to lack of competing reactions. The purities of the products <lb/>from the reactions run in DMF (reagent 13{2}) were in the range 60 to 92% (70% average). These <lb/>lower purities could be due to partial decomposition of the isocyanates at the temperature used for the <lb/>reactions in DMF. The reactions carried out with reagent 13{3} gave a mixture of the expected ethyl <lb/>esters 5{1-6,3}, the methyl esters 5{1-6,9} (from transesterification of the ethyl ester on the R group <lb/>by methoxide, formed in the cyclization), the acids 5{1-6,10} (from hydrolysis of the esters), and the <lb/>deorganylated compounds 5{1-6,11} (Figure 5 and Table 4). The overall cyclization reaction worked <lb/>well, since products 5{1-6,9}, 5{1-6,10}, and 5{1-6,11} were formed from 5{1-6,3}. Shorter <lb/>reaction times should thus be used to avoid these side reactions. <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2276 <lb/></page>

			<body>Figure 5. Products formed from the reaction with reagent 13{3}. <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>Ar <lb/>5{1-6,3} <lb/>CO 2 Et <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>Ar <lb/>5{1-6,9} <lb/>CO 2 Me <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>Ar <lb/>5{1-6,10} <lb/>CO 2 H <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>H <lb/>Ar <lb/>5{1-6,11} <lb/>The above-mentioned deorganylation side reaction could have taken place through an E1cB <lb/>mechanism (Scheme 5). The substrate 5{1-6,3} (or 5{1-6,9}) is deprotonated to form the enolate <lb/>5{1-6,12}, which undergoes an elimination reaction to afford 5{1-6,11} after work-up. <lb/>Scheme 5. Formation of compounds 5{1-6,11}. <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>CO 2 Et <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>CO 2 Et <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>MeN <lb/>NH <lb/>H <lb/>N <lb/>O <lb/>O <lb/>base <lb/>work-up <lb/>5{1-6,3} <lb/>5{1-6,11} <lb/>5{1-6,12} <lb/>Ar <lb/>Ar <lb/>Ar <lb/>Ar <lb/>The aryl-substituted dihydrouracils underwent hydrolysis (and not the alkyl-substituted <lb/>dihydrouracils) because the electrophilicity of the ureide carbonyls is enhanced (with respect to the <lb/>alkyl group) due to the conjugation of the imide-type nitrogen with the aryl group. Thus, residual H 2 O <lb/>from KOBu t could have hydrolyzed the ureide to the ureido acid [48]. <lb/>Table 4. Parallel synthesis of spiro dihydrouracil library 5{1-6,1-3} a,b . <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>Ph <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>R <lb/>5{1,1} <lb/>51% (89%) <lb/>5{1,2} <lb/>63% (70%) <lb/>5{1,3} <lb/>80% (91%) c <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>OMe <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>Ph <lb/>OMe <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>R <lb/>OMe <lb/>5{2,1} <lb/>60% (93%) <lb/>5{2,2} <lb/>64% (60%) <lb/>5{2,3} <lb/>49% (88%) c <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2277 <lb/></page>

			<body>Table 4. Cont. <lb/>MeN <lb/>OMe <lb/>OMe <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>MeN <lb/>OMe <lb/>OMe <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>Ph <lb/>MeN <lb/>OMe <lb/>OMe <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>R <lb/>5{3,1} <lb/>66% (90%) <lb/>5{3,2} <lb/>60% (68%) <lb/>5{3,3} <lb/>54% (95%) c <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>O <lb/>O <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>Ph <lb/>O <lb/>O <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>R <lb/>O <lb/>O <lb/>5{4,1} <lb/>63% (95%) <lb/>5{4,2} <lb/>64% (68%) <lb/>5{4,3} <lb/>61% (98%) c <lb/>MeN <lb/>N <lb/>Me <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>MeN <lb/>N <lb/>Me <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>Ph <lb/>MeN <lb/>N <lb/>Me <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>R <lb/>5{5,1} <lb/>61% (99%) <lb/>5{5,2} <lb/>54% (92%) <lb/>5{5,3} <lb/>66% (79%) c <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>N <lb/>Me <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>N <lb/>Me <lb/>Ph <lb/>MeN <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>R <lb/>N <lb/>Me <lb/>5{6,1} <lb/>69% (69%) <lb/>5{6,2} <lb/>68% (62%) <lb/>5{6,3} <lb/>62% (86%) c <lb/>a % = Crude yield based on mass recovery; b (%) = Purity determined by LC-MS at 215 nm; <lb/>c Mixture of compounds, R = CH 2 CH 2 CO 2 Et, CH 2 CH 2 CO 2 Me, CH 2 CH 2 CO 2 H, and H. <lb/>Table 5. Parallel synthesis of α-ureidomethyl acid library 14{1-6,4-8} a,b . <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>CF 3 <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>OEt <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>CN <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>14{1,4} <lb/>49% (&gt;99%) <lb/>14{1,5} <lb/>75% (97%) <lb/>14{1,6} <lb/>48% (&gt;99%) <lb/>14{1,7} <lb/>54% (&gt;99%) <lb/>14{1,8} <lb/>49% (79%) <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>OMe <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>OMe <lb/>CF 3 <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>OMe <lb/>OEt <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>OMe <lb/>CN <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>OMe <lb/>14{2,4} <lb/>60% (99%) <lb/>14{2,5} <lb/>65% (98%) <lb/>14{2,6} <lb/>70% (&gt;99%) <lb/>14{2,7} <lb/>60% (96%) <lb/>14{2,8} <lb/>45% (76%) <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2278 <lb/></page>

			<body>Table 5. Cont. <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>OMe <lb/>OMe <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>OMe <lb/>OMe <lb/>CF 3 <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>OMe <lb/>OMe <lb/>OEt <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>OMe <lb/>OMe <lb/>CN <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>OMe <lb/>OMe <lb/>14{3,4} <lb/>76% (97%) <lb/>14{3,5} <lb/>63% (99%) <lb/>14{3,6} <lb/>52% (99%) <lb/>14{3,7} <lb/>58% (&gt;99%) <lb/>14{3,8} <lb/>48% (43%) <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>O <lb/>O <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>O <lb/>O <lb/>CF 3 <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>O <lb/>O <lb/>OEt <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>O <lb/>O <lb/>CN <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>O <lb/>O <lb/>14{4,4} <lb/>74% (&gt;99%) <lb/>14{4,5} <lb/>68% (&gt;99%) <lb/>14{4,6} <lb/>61% (77%) c <lb/>14{4,7} <lb/>62% (99%) <lb/>14{4,8} <lb/>54% (71%) <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>Me <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>CF 3 <lb/>Me <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>OEt <lb/>Me <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>CN <lb/>Me <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>N <lb/>Me <lb/>14{5,4} <lb/>58% (14%) d <lb/>14{5,5} <lb/>65% (79%) e <lb/>14{5,6} <lb/>62% (16%) f <lb/>14{5,7} <lb/>61% (99%) <lb/>14{5,8} <lb/>56% (0%) g <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>Me <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>CF 3 <lb/>Me <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>OEt <lb/>Me <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>CN <lb/>Me <lb/>MeN <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>CO 2 H <lb/>N <lb/>N <lb/>Me <lb/>14{6,4} <lb/>79% (97%) h <lb/>14{6,5} <lb/>76% (&gt;99%) <lb/>14{6,6} <lb/>70% (94%) i <lb/>14{6,7} <lb/>67% (99%) <lb/>14{6,8} <lb/>71% (36%) <lb/>a % = Crude yield based on mass recovery; b (%) = Purity determined by LC-MS at 215 nm; c Plus <lb/>5{4,6} (21%). d Plus 5{5,4} (77%); e Plus 5{5,5} (18%). f Plus 5{5,6} (81%); g Plus 5{5,8} (54%); <lb/>h Plus 5{6,4} (2%); i Plus 5{6,6} (5%). <lb/>In order to find conditions for the exclusive formation of the spiro dihydrouracils using aryl <lb/>isocyanates, the α-ureidomethyl ester 15{1,4} was synthesized, isolated, and reacted with several <lb/>bases under different conditions for the formation of spiro dihydrouracil 5{1,4} (Table 6). <lb/>Firstly, the reaction was attempted with an easy-to-handle base because, if successful, it would <lb/>make the work-up of the reactions easy-an important factor in parallel synthesis. All the amines used <lb/>were found to have insufficient basicity for this transformation to take place (entries 1-5) [49-51]. The <lb/>amidine DBU gave promising results, but the separation of the product 5{1,4} from DBU (and <lb/>especially from the coreagent Bu 4 NBr, entry 8) was difficult and tedious, making these reaction <lb/>conditions unsuitable for parallel synthesis [52,53]. Potassium tert-butoxide was the only base that <lb/>caused &gt;99% of the starting material to react [54], but it was the base that gave the largest amount of <lb/>hydrolyzed product 14{1,4} (entries 9-12). Heating only (entry 15) resulted in decomposition of the <lb/>starting material. To the best of our knowledge, there is no example in the literature of a dihydrouracil <lb/>ring with such a tendency toward hydrolysis under basic conditions. This cyclization can also take <lb/>place using acid catalysis [55-58], but this has not yet been attempted. <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2279 <lb/></page>

			<body>Table 6. Optimization of the formation of spiro dihydrouracil 5{1,4}. <lb/>MeN <lb/>Ph <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>Ph <lb/>MeN <lb/>Ph <lb/>N <lb/>H <lb/>N <lb/>H <lb/>O <lb/>Ph <lb/>MeN <lb/>Ph <lb/>NH <lb/>N <lb/>O <lb/>O <lb/>Ph <lb/>+ <lb/>15{1,4} <lb/>5{1,4} <lb/>14{1,4} <lb/>CO 2 Me <lb/>CO 2 H <lb/>Entry <lb/>Conditions <lb/>Products a <lb/>15{1,4}/5{1,4}/14{1,4} <lb/>1 <lb/>Et 3 N (1.1 equiv), THF, Ar, reflux, 22 h <lb/>1:0:0 <lb/>2 <lb/>Proton sponge (0.2 equiv), THF, 21 °C, 5 h <lb/>1:0:0 <lb/>3 <lb/>Proton sponge (1 equiv), THF, 21 °C, 17 h <lb/>1:0:0 <lb/>4 <lb/>Proton sponge (1 equiv), THF, reflux, 7 h <lb/>1:0:0 <lb/>5 <lb/>DIPEA (1 equiv), DMF, 90 °C, 6 h <lb/>1:0:0 <lb/>6 <lb/>DBU (1 equiv), THF, Ar, 26 °C, 5 h <lb/>1:0:0 <lb/>7 <lb/>DBU (1 equiv), THF, Ar, reflux, 17 h <lb/>5:1:0 <lb/>8 <lb/>DBU (1 equiv), Bu 4 NBr, 4 Å MS, PhMe, Ar, reflux, 27 h <lb/>1:9:0 <lb/>9 <lb/>KOBu t (1 equiv), THF, 29 °C, 30 min <lb/>1:3:1 <lb/>10 <lb/>KOBu t (1 equiv), THF, 31 °C, 55 min <lb/>0:2:1 <lb/>11 <lb/>KOBu t (1 equiv), THF, Ar, 21 °C, 2 h <lb/>0:1:2 <lb/>12 <lb/>KOBu t (0.1 equiv), THF, Ar, 21 °C, 17 h <lb/>3:6:1 <lb/>13 <lb/>Phosphazene P 2 -t-Bu (0.1 equiv), THF, Ar, 21 °C, 5 h <lb/>1:3:0 <lb/>14 <lb/>Phosphazene P 2 -t-Bu (1 equiv), THF, Ar, 21 °C, 18 h <lb/>1:0:4 <lb/>15 <lb/>DMSO, 165 °C, 15 h <lb/>decomposition <lb/>a Ratio calculated by integration of the 1 H-NMR signals of the crude reaction mixture. <lb/>The compounds 5{1-6,1-3}, 5{1,4}, 6{1-6}, 14{1-6,4-8}, and 15{1,4} were tested on different <lb/>CNS targets, but the results cannot be published because of the patent policy of the companies <lb/>involved in the project. <lb/>3. Experimental <lb/>3.1. General <lb/>Reagents were obtained from commercial suppliers and were used without purification. Solvents <lb/>were distilled from appropriate drying agents prior to use and were stored under nitrogen. Reactions <lb/>were followed, and R F values were obtained, using thin-layer chromatography (TLC) on silica gel-<lb/>coated plates (Merck 60 F254) with the indicated solvent mixture. Detection was performed with UV <lb/>light and/or by charring at ca. 150 °C after dipping into a solution of KMnO 4 or ninhydrin. Column or <lb/>flash chromatography was carried out using ACROS silica gel (0.035-0.070 mm, pore diameter <lb/>ca. 6 nm). IR spectra were recorded on an ATI Mattson Genesis Series FTIR spectrometer. High-<lb/>resolution mass spectra were recorded on a JEOL AccuTOF (ESI) or a MAT900 (EI, CI, and ESI). <lb/>Low-resolution ESI mass spectra were recorded on a Thermo Finnigan LCQ Advantage Max Ion Trap <lb/>mass spectrometer. Elemental analyses were carried out using a Carlo Erba Instruments CHNS-O EA <lb/>1108 element analyzer. Melting points were analyzed with a Büchi melting point B-545 and are not <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2280 <lb/></page>

			<body>corrected. Gas chromatography (GC) was performed on a Hewlett Packard 5890, containing a HP1 <lb/>column (25 m x 0.32 mm x 0.17 μm), FID detection, and equipped with a HP3393A integrator. NMR <lb/>spectra were recorded at 298 K on a Bruker DMX 300 (300 MHz) or a Varian 400 (400 MHz) <lb/>spectrometer in the solvent indicated. Chemical shifts are given in parts per million (ppm) with respect <lb/>to tetramethylsilane (0.00 ppm) or CD 3 SOCHD 2 (2.50 ppm) as internal standard for 1 H-NMR; and <lb/>CDCl 3 (77.16 ppm) or CD 3 SOCD 3 (39.52 ppm) as internal standard for 13 C-NMR [59]. Coupling <lb/>constants are reported as J values in hertz (Hz). Multiplicity data are denoted by s (singlet), d (doublet), <lb/>t (triplet), q (quartet), m (multiplet), b (broad), and app (apparent). Peak assignment in 13 C spectra are <lb/>based on 2D gHSQC and gHMBC spectra, and DEPT 135 when needed. Chain numbering <lb/>corresponds to IUPAC nomenclature, so unprimed atoms belong to the principal chain, primed atoms <lb/>belong to the first named substituent, doubled-primed atoms to the second named substituent, etc. LC-<lb/>MS measurements were run on a Shimadzu LC-10A VP series liquid chromatography system, <lb/>equipped with an SPD-10A VP UV-vis detector and a LCMS-2010A mass spectrometer. The column <lb/>used for the LC analysis was an Agilent Zorbax Extend C18 (3.5 μm, 4.6 × 150 mm), and it was eluted <lb/>at 1 mL/min with a gradient made up of two solvent mixtures. Solvent A consisted of 0.1% <lb/>trifluoroacetic acid in water and solvent B consisted of 0.1% trifluoroacetic acid in acetonitrile. The <lb/>gradient was run as follows: t ) 0 min, 50% A; t ) 5 min, 5% A; t ) 10 min, 5% A; t ) 12.5 min, 50% A; <lb/>t ) 20 min, 50% A. A wavelength of 215 nm was selected for the analysis of purity. <lb/>3.2. General procedure for Knoevenagel condensation reaction <lb/>Piperidine (5 drops) was added to a solution of methyl 2-cyanoacetate (9) and the aldehyde 10 <lb/>(1.0 equiv) in MeOH. The resulting reaction mixture was stirred at room temperature for the time <lb/>indicated in each case. The reaction mixture was filtered and the precipitate was recrystalized from <lb/>MeOH. The filtrate was concentrated under reduced pressure and purified by recrystalization from <lb/>MeOH. <lb/>Methyl (E)-2-cyano-3-phenylacrylate (8{1}): According to the general procedure, the reaction of <lb/>methyl 2-cyanoacetate (9, 7.940 g, 80.13 mmol) with benzaldehyde 10{1} (8.504 g, 80.13 mmol) over <lb/>30 min afforded 8{1} (14.910 g, 99%) as a white solid. 1 H-NMR [400 MHz, δ (ppm), CDCl 3 ]: 8.21 (s, <lb/>1 1 H, 3-CH), 7.97-7.92 (m, 2 1 H, 2′-CH + 6′-CH), 7.56-7.43 (m, 3 1 H, 3′-CH + 4′-CH + 5′-CH), 3.90 <lb/>(s, 3 1 H, OCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 162.5 (CO 2 ), 154.9 (3-C), 133.1 (4′-C), 131.1 <lb/>(1′-C), 130.8 (2′-C + 6′-C), 129.0 (3′-C + 5′-C), 115.2 (CN), 102.4 (2-C), 53.4 (OCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -<lb/>1 ), neat]: 3036, 2954, 2224, 1727, 1606, 1200, 767, 685. Elem. anal. calcd. for C 11 H 9 NO 2 : C 70.58%, <lb/>H 4.85%, N 7.48%; found C 70.39%, H 4.54%, N 7.43%. R F : 0.63 (heptane/AcOEt, 1:1). Mp: 87.9 °C <lb/>(from MeOH, colorless flake-like crystals). Purity: &gt;99.5% (GC). <lb/>Methyl (E)-2-cyano-3-(4-methoxyphenyl)acrylate (8{2}): According to the general procedure, the <lb/>reaction of methyl 2-cyanoacetate (9, 6.804 g, 68.66 mmol) with 4-methoxybenzaldehyde 10{2} <lb/>(9.349 g, 68.66 mmol) over 30 min afforded 8{2} (14.020 g, 94%) as a white solid. 1 H-NMR [400 <lb/>MHz, δ (ppm), CDCl 3 ]: 8.14 (s, 1 1 H, 3-CH), 8.00-7.95 (m, 2 1 H, 2′-CH + 6′-CH), 7.01-6.95 (m, 2 1 H, <lb/>3′-CH + 5′-CH), 3.91 (s, 3 1 H, CO 2 CH 3 ), 3.88 (s, 3 1 H, OCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: <lb/>163.8 (4′-C), 163.5 (CO 2 ), 154.5 (3-C), 133.6 (2′-C + 6′-C), 124.2 (1′-C), 116.1 (CN), 114.7 (3′-C + 5′-<lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2281 <lb/></page>

			<body>C), 98.8 (2-C), 55.6 (OCH 3 ), 53.1 (CO 2 CH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3084, 2954, 2846, 2215, 1714, <lb/>1580, 1264, 1174, 841. Elem. anal. calcd. for C 12 H 11 NO 3 : C 66.35%, H 5.10%, N 6.45%; found C <lb/>66.24%, H 4.98%, N 6.33%. R F : 0.58 (heptane/AcOEt, 1:1). Mp: 104.1 °C (from MeOH, off-white <lb/>small crystals). Purity: &gt;99.5% (GC). <lb/>Methyl (E)-2-cyano-3-(3,5-dimethoxyphenyl)acrylate (8{3}): According to the general procedure, the <lb/>reaction of methyl 2-cyanoacetate (9, 5.835 g, 58.89 mmol) with 3,5-dimethoxybenzaldehyde 10{3} <lb/>(9.785 g, 58.89 mmol) over 40 min afforded 8{3} (12.399 g, 99%) as a yellow solid. 1 H-NMR [400 <lb/>MHz, δ (ppm), CDCl 3 ]: 8.17 (s, 1 1 H, 3-CH), 7.15 (d, J = 2.4 Hz, 2 1 H, 2′-CH + 6′-CH), 6.65 (t, J = 2.4 <lb/>Hz, 1 1 H, 4′-CH), 3.94 (s, 3 1 H, CO 2 CH 3 ), 3.84 (s, 6 1 H, 2 × OCH 3 ). 13 C-NMR [75 MHz, δ (ppm), <lb/>CDCl 3 ]: 163.1 (CO 2 ), 161.2 (3′-C + 5′-C), 155.6 (3-C), 133.1 (1′-C), 115.6 (CN), 108.7 (2′-C + 6′-C), <lb/>106.4 (4′-C), 103.0 (2-C), 55.8 (2 × OCH 3 ), 53.6 (CO 2 CH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3086, 2940, 2841, <lb/>2217, 1723, 1604, 1247, 1167, 840. Elem. anal. calcd for C 13 H 13 NO 4 : C 63.15%, H 5.30%, N 5.66%; <lb/>found C 63.22%, H 5.14%, N 5.53%. R F : 0.56 (heptane/AcOEt, 1:1). Mp: 121.5 °C (from MeOH, long <lb/>light yellow needles). Purity: &gt;99.5% (GC). <lb/>Methyl (E)-3-(1,3-benzodioxol-5-yl)-2-cyanoacrylate (8{4}): According to the general procedure, the <lb/>reaction of methyl 2-cyanoacetate (9, 6.002 g, 60.57 mmol) with piperonal 10{4} (9.094 g, 60.57 <lb/>mmol) over 60 min afforded 8{4} (13.836 g, 99%) as a light greenish solid. 1 H-NMR [400 MHz, δ <lb/>(ppm), CDCl 3 ]: 8.12 (s, 1 1 H, 3-CH), 7.71 (d, J = 1.9 Hz, 1 1 H, 4′-CH), 7.41 (ddd; J = 8.2, 1.9, 0.6 Hz; <lb/>1 1 H, 6′-CH), 6.91 (d, J = 8.2 Hz, 1 1 H, 7′-CH), 6.09 (s, 2 1 H, 2′-CH 2 ), 3.92 (s, 3 1 H, OCH 3 ). 13 C-NMR <lb/>[75 MHz, δ (ppm), CDCl 3 ]: 163.6 (CO 2 ), 154.7 (3-C), 152.5 (7′a-C), 148.8 (3′a-C), 130.0 (6′-C), 126.1 <lb/>(5′-C), 116.1 (CN), 109.1 (4′-C), 109.0 (7′-C), 102.5 (2′-C), 99.5 (2-C), 53.4 (OCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), <lb/>neat]: 3029, 2957, 2218, 1723, 1579, 1244, 1205, 1041, 922, 819. HRMS [EI (m/z)] calcd for <lb/>C 12 H 9 NO 4 = 231.0532, found for [M +• ] = 231.0532 (|Δ| = 0.0 ppm), peaks at (relative intensity): 231 <lb/>(100), 200 (21), 170 (32), 142 (12), 114 (21). Elem. anal. calcd for C 12 H 9 NO 4 : C 62.34%, H 3.92%, N <lb/>6.06%; found C 62.24%, H 3.86%, N 6.00%. R F : 0.60 (heptane/AcOEt, 1:1). Mp: 169.6 °C (from <lb/>MeOH, light green cotton-like solid). Purity: &gt;99.5% (GC). <lb/>Methyl (E)-2-cyano-3-(1-methyl-1H-pyrrol-2-yl)acrylate (8{5}): According to the general procedure, <lb/>the reaction of methyl 2-cyanoacetate (9, 7.107 g, 71.72 mmol) with 1-methyl-1H-pyrrole-2-<lb/>carbaldehyde 10{5} (7.827 g, 71.72 mmol) over 120 min afforded 8{5} (12.932 g, 95%) as a yellow <lb/>solid. 1 H-NMR [400 MHz, δ (ppm), CDCl 3 ]: 8.08 (s, 1 1 H, 3-CH). 7.72 (d, J = 4.4 Hz, 1 1 H, 3′-CH), <lb/>7.01 (t, J = 1.8 Hz, 1 1 H, 5′-CH), 6.39-6.36 (m, 1 1 H, 4′-CH), 3.89 (s, 3 1 H, OCH 3 ), 3.78 (s, 3 1 H, <lb/>NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 164.8 (CO 2 ), 139.6 (3-C), 131.7 (5′-C), 127.5 (2′-C), <lb/>120.0 (3′-C), 117.1(CN), 112.2 (4′-C), 92.8 (2-C), 53.0 (OCH 3 ), 34.4 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: <lb/>3120, 2957, 2899, 2210, 1717, 1591, 1243, 748. Elem. anal. calcd for C 10 H 10 N 2 O 2 : C 63.15%, H <lb/>5.30%, N 14.73%; found C 63.19%, H 5.09%, N 14.70%. R F : 0.29 (heptane/AcOEt, 1:1). Mp: 154.2 <lb/>°C (from MeOH, yellow solid). Purity: &gt;99.5% (GC). <lb/>Methyl (E)-2-cyano-3-(1-methyl-1H-indol-3-yl)acrylate (8{6}): According to the general procedure, <lb/>the reaction of methyl 2-cyanoacetate (9, 6.011 g, 60.66 mmol) with 1-methyl-1H-indole-3-<lb/>carbaldehyde 10{6} (9.656 mg, 60.66 mmol) over 120 min afforded 8{6} (13.977 g, 96%) as a yellow <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2282 <lb/></page>

			<body>solid. 1 H-NMR [400 MHz, δ (ppm), CDCl 3 ]: 8.56 (s, 1 1 H, 3-CH), 8.49 (s, 1 1 H, 2′-CH), 7.84-7.80 <lb/>(m, 1 1 H, 4′-CH), 7.42-7.31 (m, 3 1 H, 5′-CH + 6′-CH + 7′-CH), 3.91 (s, 3 1 H, CO 2 CH 3 ), 3.90 (s, 3 1 H, <lb/>NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 164.6 (CO 2 ), 146.2 (3-C), 137.0 (7′a-C), 134.9 (2′-C), <lb/>128.5 (3′a-C), 124.1 (6′-C), 122.8 (5′-C), 118.6 (4′-C), 118.5 (CN), 110.6 (7′-C), 110.1 (3′-C), 93.3 (2-<lb/>C), 52.9 (OCH 3 ), 34.2 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3118, 3026, 2950, 2222, 1701, 1586, 1255, 751. <lb/>HRMS [EI (m/z)] calcd for C 14 H 12 N 2 O 2 = 240.0899, found for [M +• ] = 240.0895 (|Δ| = 1.6 ppm), peaks <lb/>at (relative intensity): 240 (100), 209 (53), 140 (18), 49 (12). Elem. anal. calcd for C 14 H 12 N 2 O 2 : C <lb/>69.99%, H 5.03%, N 11.66%; found C 69.69%, H 4.85%, N 11.42%. R F : 0.37 (heptane/AcOEt, 1:1). <lb/>Mp: 165.9 °C (from MeOH, yellow solid). Purity: &gt;99.5% (GC). <lb/>Methyl (E)-2-cyano-3-(1H-pyrrol-2-yl)acrylate (8{7}): According to the general procedure, the <lb/>reaction of methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with 1H-pyrrole-2-carbaldehyde 10{7} <lb/>(951 mg, 10.00 mmol) over 30 min afforded 8{7} (1.744 g, 99%) as a yellow solid. 1 H-NMR [400 <lb/>MHz, δ (ppm), CDCl 3 ]: 9.92 (bs, 1 1 H, NH), 8.02 (s, 1 1 H, 3-CH), 7.26-7.23 (m, 1 1 H, 5′-CH), 6.98-<lb/>6.94 (m, 1 1 H, 3′-CH), 6.44 (dt; J = 3.9, 2.3 Hz; 1 1 H, 4′-CH), 3.89 (s, 3 1 H, OCH 3 ). 13 C-NMR [75 <lb/>MHz, δ (ppm), CDCl 3 ]: 164.2 (CO 2 ), 142.8 (3-C), 128.4 (5′-C), 127.0 (2′-C), 124.7 (3′-C), 118.6 (CN), <lb/>112.7 (4′-C), 91.8 (2-C), 53.0 (OCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3300, 3032, 2950, 2215, 1692, 1593, <lb/>1221, 750. Elem. anal. calcd for C 9 H 8 N 2 O 2 : C 61.36%, H 4.58%, N 15.90%; found C 61.45%, H <lb/>4.58%, N 15.79%. R F : 0.37 (heptane/AcOEt, 1:1). Mp: 140.2 °C (from MeOH, small thin yellow <lb/>needles). Purity: &gt;99.5% (GC). <lb/>Methyl (E)-2-cyano-3-(1H-indol-3-yl)acrylate (8{8}): According to the general procedure, the reaction <lb/>of methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with 1H-indole-3-carbaldehyde 10{8} (1.452 g, <lb/>10.00 mmol) in THF (15 mL) over 480 min afforded 8{8} (2.239 g, 99%) as a yellow solid. 1 H-NMR <lb/>[400 MHz, δ (ppm), CD 3 SOCD 3 ]: 12.64 (bs, 1 1 H, NH), 8.64 (s, 1 1 H, 2′-CH), 8.63 (s, 1 1 H, 3-CH), <lb/>8.05-7.99 (m, 1 1 H, 4′-CH), 7.67-7.63 (m, 1 1 H, 7′-CH), 7.41-7.30 (m, 2 1 H, 5′-CH + 6′-CH), 3.92 (s, <lb/>3 1 H, OCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CD 3 SOCD 3 ]: 163.3 (CO 2 ), 146.3 (3-C), 135.9 (7′a-C), <lb/>132.4 (2′-C), 126.6 (3′a-C), 123.3 (6′-C), 121.9 (5′-C), 118.3 (4′-C), 117.8 (CN), 112.7 (7′-C), 109.7 <lb/>(3′-C), 91.8 (2-C), 52.6 (OCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3266, 3132, 2989, 2943, 2212, 1695, 1589, <lb/>1241, 742. Elem. anal. calcd for C 13 H 10 N 2 O 2 : C 69.02%, H 4.46%, N 12.38%; found C 68.97%, H <lb/>4.38%, N 12.22%. R F : 0.80 (AcOEt). Mp: 189.5 °C (from MeOH, yellow needles). Purity: &gt;99.5% <lb/>(GC). <lb/>Methyl (E)-2-cyano-3-(2-thienyl)acrylate (8{9}): According to the general procedure, the reaction of <lb/>methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with thiophene-2-carbaldehyde 10{9} (1.121 g, 10.00 <lb/>mmol) over 30 min afforded 8{9} (1.816 g, 94%) as a light brown solid. 1 H-NMR [400 MHz, δ (ppm), <lb/>CDCl 3 ]: 8.36 (s, 1 1 H, 3-CH), 7.84 (d, J = 3.9 Hz, 1 1 H, 3′-CH), 7.80 (d, J = 4.9 Hz, 1 1 H, 5′-CH), 7.24 <lb/>(dd; J = 4.9, 3.9 Hz; 1 1 H, 4′-CH), 3.92 (s, 3 1 H, OCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 162.9 <lb/>(CO 2 ), 146.7 (3-C), 137.2 (3′-C), 135.8 (2′-C), 135.2 (5′-C), 128.6 (4′-C), 115.6 (CN), 98.8 (2-C), 53.4 <lb/>(OCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3087, 3028, 2964, 2216, 1718, 1590, 1271, 1214, 729. Elem. anal. <lb/>calcd for C 9 H 7 NO 2 S: C 55.94%, H 3.65%, N 7.25%; found C 55.98%, H 3.63%, N 7.23%. R F : 0.61 <lb/>(heptane/AcOEt, 1:1). Mp: 106.9 °C (from MeOH, light brown needles). Purity: &gt;99.5% (GC). <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2283 <lb/></page>

			<body>Methyl (E)-2-cyano-3-(2-pyridyl)acrylate (8{10}): According to the general procedure, the reaction of <lb/>methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with pyridine-2-carbaldehyde 10{10} (1.071 g, 10.00 <lb/>mmol) over 30 min afforded 8{10} (1.863 g, 99%) as a brown solid. 1 H-NMR [400 MHz, δ (ppm), <lb/>CDCl 3 ]: 8.83 (ddd; J = 4.8, 1.6, 1.0 Hz; 1 1 H, 6′-CH), 8.30 (s, 1 1 H, 3-CH), 7.89 (app dt; J = 7.8, 1.2 <lb/>Hz; 1 1 H, 3′-CH), 7.85 (app dt; J = 1.6, 7.8 Hz; 1 1 H, 4′-CH), 7.44 (ddd; J = 7.3, 4.9, 1.5 Hz; 1 1 H, 5′-<lb/>CH), 3.96 (s, 3 1 H, OCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 162.6 (CO 2 ), 153.7 (3-C), 150.7 (6′-<lb/>C), 150.0 (2′-C), 137.1 (4′-C), 126.8 (5′-C), 126.4 (3′-C), 114.8 (CN), 106.4 (2-C), 53.7 (OCH 3 ). FTIR <lb/>[ <lb/>_ <lb/>ν (cm -1 ), neat]: 3050, 2963, 2220, 1720, 1278, 1215, 781, 740. Elem. anal. calcd for C 10 H 8 N 2 O 2 : C <lb/>63.83%, H 4.28%, N 14.89%; found C 64.06%, H 4.26%, N 14.79%. R F : 0.34 (heptane/AcOEt, 1:1). <lb/>Mp: 131.7 °C (from MeOH, small brown needles). Purity: &gt;99.5% (GC). <lb/>Methyl (E)-2-cyano-3-(3-pyridyl)acrylate (8{11}): According to the general procedure, the reaction of <lb/>methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with pyridine-3-carbaldehyde 10{11} (1.071 g, 10.00 <lb/>mmol) over 90 min afforded 8{11} (1.750 g, 93%) as a light yellow dust. 1 H-NMR [300 MHz, δ <lb/>(ppm), CDCl 3 ]: 8.91 (d, J = 1.8 Hz, 1 1 H, 2′-CH), 8.74 (dd; J = 4.8, 1.8 Hz; 1 1 H, 6′-CH), 8.57-8.51 <lb/>(m, 1 1 H, 4′-CH), 8.26 (s, 1 1 H, 3-CH), 7.46 (dd; J = 7.8, 4.8 Hz; 1 1 H, 5′-CH), 3.95 (s, 3 1 H, OCH 3 ). <lb/>13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 161.9 (CO 2 ), 153.3 (3-C), 152.7 (6′-C), 151.3 (2′-C), 135.8 (4′-<lb/>C), 127.3 (3′-C), 123.9 (5′-C), 114.7 (CN), 105.1 (2-C), 53.8 (OCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3031, <lb/>2959, 2223, 1722, 1280, 697. R F : 0.13 (heptane/AcOEt, 1:1). Mp: 129.2 °C. <lb/>Methyl (E)-2-cyano-3-(4-pyridyl)acrylate (8{12}): According to the general procedure, the reaction of <lb/>methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with pyridine-4-carbaldehyde 10{12} (1.071 g, 10.00 <lb/>mmol) over 25 min afforded 8{12} (1.863 g, 99%) as a pink solid. 1 H-NMR [400 MHz, δ (ppm), <lb/>CDCl 3 ]: 8.86-8.80 (m, 2 1 H, 2′-CH + 6′-CH), 8.23 (s, 1 1 H, 3-CH), 7.80-7.74 (m, 2 1 H, 3′-CH + 5′-<lb/>CH), 3.97 (s, 3 1 H, OCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 161.8 (CO 2 ), 152.4 (3-C), 151.2 (2′-<lb/>C + 6′-C), 138.0 (4′-C), 123.3 (3′-C + 5′-C), 114.2 (CN), 107.8 (2-C), 53.8 (OCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), <lb/>neat]: 3033, 2955, 2225, 1726, 1236, 1198, 818. Elem. anal. calcd for C 10 H 8 N 2 O 2 : C 63.83%, H <lb/>4.28%, N 14.89%; found C 63.94%, H 4.25%, N 14.75%. R F : 0.12 (heptane/AcOEt, 1:1). Mp: <lb/>126.6 °C (from MeOH, small pink needles). Purity: &gt;99.5% (GC). <lb/>3.3. General procedure for 1,3-dipolar cycloaddition reactions of 8 <lb/>A round-bottomed flask fitted with a Dean-Stark apparatus, a reflux condenser, and a drying tube <lb/>containing calcium chloride was charged with 2-cyanoacrylate 8 and toluene (0.20-0.25 M). When the <lb/>mixture was under reflux, sarcosine (N-methylglycine; 1.2 equiv) and paraformaldehyde (3.6 equiv) <lb/>were added. This addition was repeated every 40 min until the substrate had completely reacted. Water <lb/>(20 mL) was then added and the layers were separated. The aqueous layer was extracted with Et 2 O <lb/>(3 × 30 mL) and the combined organic layers were dried (MgSO 4 ), filtered, and concentrated in vacuo. <lb/>(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-phenylpyrrolidine-3-carboxylate (7{1}): According to the <lb/>general procedure, 2-cyanoacrylate 8{1} (5.342 g, 28.54 mmol) afforded 7{1} (6.524 g, 94%) as a <lb/>white solid, after column chromatography (heptane/AcOEt, 3:1→2:1). 1 H-NMR [400 MHz, δ (ppm), <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2284 <lb/></page>

			<body>CDCl 3 ]: 7.33-7.19 (m, 5 1 H, Ph), 4.00 (app t, J = 7.8 Hz, 1 1 H, 4-CH), 3.70 (s, 3 1 H, OCH 3 ), 3.25 (d, J <lb/>= 9.9 Hz, 1 1 H, 2-CHH), 3.18 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.04 (dd; J = 9.6, 7.8 Hz; 1 1 H, 5-CHH), <lb/>3.00 (dd; J = 9.6, 8.1 Hz; 1 1 H, 5-CHH), 2.38 (s, 3 1 H, NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: <lb/>167.6 (CO 2 ), 136.6 (1′-C), 128.0 (2′-C + 6′-C), 127.9 (3′-C + 5′-C), 127.5 (4′-C), 117.2 (CN), 64.9 (2-<lb/>C), 60.2 (5-C), 54.4 (3-C), 53.5 (CO 2 CH 3 ), 51.8 (4-C), 41.1 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 2950, <lb/>2846, 2790, 2241, 1740, 1247, 772, 699. MS [ESI (m/z)] calcd for (C 14 H 16 N 2 O 2 + H) + = 245, found <lb/>245. R F : 0.24 (heptane/AcOEt, 1:1). Mp: 53.3 °C (from heptane, colorless crystals). Purity: &gt;99.5% <lb/>(GC). <lb/>(±)-Methyl <lb/>(3R,4R)-3-cyano-4-(4-methoxyphenyl)-1-methylpyrrolidine-3-carboxylate <lb/>(7{2}): <lb/>According to the general procedure, 2-cyanoacrylate 8{2} (6.162 g, 28.37 mmol) afforded 7{2} (7.688 <lb/>g, 99%) as a yellow oil. 1 H-NMR [400 MHz, δ (ppm), CDCl 3 ]: 7.28-7.22 (m, 2 1 H, 2′-CH + 6′-CH), <lb/>6.87-6.82 (m, 2 1 H, 3′-CH + 5′-CH), 3.98 (app t, J = 8.0 Hz, 1 1 H, 4-CH), 3.80 (s, 3 1 H, CO 2 CH 3 ), 3.76 <lb/>(s, 3 1 H, OCH 3 ), 3.31 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.20 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.07 (dd; J = <lb/>9.6, 7.8 Hz; 1 1 H, 5-CHH), 3.02 (dd; J = 9.6, 8.1 Hz; 1 1 H, 5-CHH), 2.44 (s, 3 1 H, NCH 3 ). 13 C-NMR <lb/>[75 MHz, δ (ppm), CDCl 3 ]: 168.1 (CO 2 ), 159.1 (4′-C), 129.4 (2′-C + 6′-C), 128.6 (1′-C), 117.8 (CN), <lb/>113.8 (3′-C + 5′-C), 65.2 (2-C), 60.8 (5-C), 55.2 (OCH 3 ), 54.9 (3-C), 53.9 (CO 2 CH 3 ), 51.8 (4-C), 41.6 <lb/>(NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 2951, 2836, 2788, 2243, 1740, 1247, 832. MS [ESI (m/z)] calcd for <lb/>(C 15 H 18 N 2 O 3 + H) + = 275, found 275. R F : 0.23 (heptane/AcOEt, 1:1). Purity: 98.9% (GC). <lb/>(±)-Methyl (3R,4R)-3-cyano-4-(3,5-dimethoxyphenyl)-1-methylpyrrolidine-3-carboxylate <lb/>(7{3}): <lb/>According to the general procedure, 2-cyanoacrylate 8{3} (9.745 g, 39.41 mmol) afforded 7{3} <lb/>(11.398 g, 95%) as a white solid, after column chromatography (heptane/AcOEt, 3:1→2:1). 1 H-NMR <lb/>[400 MHz, δ (ppm), CDCl 3 ]: 6.51 (d, J = 2.2 Hz, 2 1 H, 2′-CH + 6′-CH), 6.41 (t, J = 2.2 Hz, 1 1 H, 4′-<lb/>CH), 3.99 (app t, J = 7.9 Hz, 1 1 H, 4-CH), 3.84 (s, 3 1 H, CO 2 CH 3 ), 3.78 (s, 6 1 H, 2 × OCH 3 ), 3.30 (d, J <lb/>= 9.9 Hz, 1 1 H, 2-CHH), 3.24 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.09 (dd; J = 9.6, 7.8 Hz; 1 1 H, 5-CHH), <lb/>3.06 (dd; J = 9.6, 8.0 Hz; 1 1 H, 5-CHH), 2.47 (s, 3 1 H, NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: <lb/>168.8 (CO 2 ), 161.1 (3′-C + 5′-C), 139.4 (1′-C), 118.1 (CN), 107.0 (2′-C + 6′-C), 100.2 (4′-C), 65.7 (2-<lb/>C), 60.7 (5-C), 55.6 (2 × OCH 3 ), 54.8 (3-C), 54.2 (CO 2 CH 3 ), 52.6 (4-C), 41.8 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -<lb/>1 ), neat]: 2948, 2837, 2790, 2243, 1743, 1595, 1203, 1155. HRMS [EI (m/z)] calcd for C 16 H 20 N 2 O 4 = <lb/>304.1423, found for [M +• ] = 304.1436 (|Δ| = 4.2 ppm), peaks at (relative intensity): 304 (16), 261 (18), <lb/>193 (11), 57 (100), 42 (20). Elem. anal. calcd for C 16 H 20 N 2 O 4 : C 63.14%, H 6.62%, N 9.20%; found C <lb/>63.33%, H 6.65%, N 9.19%. R F : 0.19 (heptane/AcOEt, 1:1). Mp: 94.7 °C (from heptane, colorless <lb/>crystals). Purity: &gt;99.5% (GC). <lb/>(±)-Methyl <lb/>(3R,4R)-4-(1,3-benzodioxol-5-yl)-3-cyano-1-methylpyrrolidine-3-carboxylate <lb/>(7{4}): <lb/>According to the general procedure, 2-cyanoacrylate 8{4} (9.774 g, 42.27 mmol) afforded 7{4} <lb/>(12.041 g, 99%) as a white solid. 1 H-NMR [400 MHz, δ (ppm), CDCl 3 ]: 6.88 (d, J = 1.7 Hz, 1 1 H, 4′-<lb/>CH), 6.81 (dd; J = 8.0, 1.7 Hz; 1 1 H, 6′-CH), 6.77 (d, J = 8.0 Hz, 1 1 H, 7′-CH), 5.95 (d, J = 1.6 Hz, 1 <lb/>1 H, 2′-CHH), 5.94 (d, J = 1.6 Hz, 1 1 H, 2′-CHH), 3.97 (t, J = 7.8 Hz, 1 1 H, 4-CH), 3.84 (s, 3 1 H, <lb/>OCH 3 ), 3.28 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.23 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.06 (dd; J = 9.5, 7.8 <lb/>Hz; 1 1 H, 5-CHH), 3.01 (dd; J = 9.5, 7.8 Hz; 1 1 H, 5-CHH), 2.45 (s, 3 1 H, NCH 3 ). 13 C-NMR [75 MHz, <lb/>δ (ppm), CDCl 3 ]: 168.5 (CO 2 ), 147.9 (3′a-C), 147.5 (7′a-C), 130.8 (5′-C), 122.0 (6′-C), 117.9 (CN), <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2285 <lb/></page>

			<body>108.8 (7′-C), 108.3 (4′-C), 101.2 (2′-C), 65.3 (2-C), 60.8 (5-C), 54.8 (3-C), 54.0 (OCH 3 ), 52.1 (4-C), <lb/>41.5 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 2965, 2900, 2788, 2242, 1740, 1249, 1036, 929. HRMS [EI <lb/>(m/z)] calcd for C 15 H 16 N 2 O 4 = 288.1110, found for [M +• ] = 288.1097 (|Δ| = 4.5 ppm), peaks at (relative <lb/>intensity): 288 (13), 57 (100), 42 (11). Elem. anal. calcd for C 15 H 16 N 2 O 4 : C 62.49%, H 5.59%, N <lb/>9.72%; found C 62.56%, H 5.61%, N 9.69%. R F : 0.22 (heptane/AcOEt, 1:1). Mp: 87.6 °C (from <lb/>heptane, colorless crystals). Purity: &gt;99.5% (GC). <lb/>(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(1-methyl-1H-pyrrol-2-yl)pyrrolidine-3-carboxylate (7{5}): <lb/>According to the general procedure, 2-cyanoacrylate 8{5} (1.132 g, 5.95 mmol) afforded 7{5} (765 <lb/>mg, 52%) as a yellow oil, after column chromatography (heptane/AcOEt, 3:1→2:1). 1 H-NMR [400 <lb/>MHz, δ (ppm), CDCl 3 ]: 6.62 (dd; J = 2.7, 1.7 Hz; 1 1 H, 5′-CH), 6.28 (dd; J = 3.6, 1.7 Hz; 1 1 H, 3′-CH), <lb/>6.14 (dd; J = 3.6, 2.7 Hz; 1 1 H, 4′-CH), 4.25 (app t, J = 8.2 Hz, 1 1 H, 4-CH), 3.87 (s, 3 1 H, OCH 3 ), 3.57 <lb/>(s, 3 1 H, 1′-NCH 3 ), 3.45 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.26 (dd; J = 9.5, 7.6 Hz; 1 1 H, 5-CHH), 3.04 <lb/>(d, J = 9.9 Hz, 1 1 H, 2-CHH), 2.84 (app t, J = 9.1 Hz, 1 1 H, 5-CHH), 2.44 (s, 3 1 H, 1-NCH 3 ). 13 C-NMR <lb/>[75 MHz, δ (ppm), CDCl 3 ]: 168.9 (CO 2 ), 128.2 (2′-C), 123.5 (5′-C), 117.2 (CN), 108.7 (4′-C), 107.6 <lb/>(3′-C), 65.2 (2-C), 61.3 (5-C), 54.2 (OCH 3 ), 53.8 (3-C), 43.7 (4-C), 41.5 (1-NCH 3 ), 34.0 (1′-NCH 3 ). <lb/>FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 2951, 2888, 2791, 2242, 1741, 1241, 717. MS [ESI (m/z)] calcd for <lb/>(C 13 H 17 N 3 O 2 + H) + = 248, found 248. R F : 0.23 (heptane/AcOEt, 1:1). Purity: 98.2% (GC). <lb/>(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(1-methyl-1H-indol-3-yl)pyrrolidine-3-carboxylate (7{6}): <lb/>According to the general procedure, 2-cyanoacrylate 8{6} (9.241 g, 38.46 mmol) afforded 7{6} <lb/>(10.831 g, 95%) as a yellow solid, after column chromatography (heptane/AcOEt, 3:1→2:1). 1 H-NMR <lb/>[400 MHz, δ (ppm), CDCl 3 ]: 7.50 (dt; J = 8.1, 1.0 Hz; 1 1 H, 4′-CH), 7.29 (dt; J = 8.3, 1.0 Hz; 1 1 H, 7′-<lb/>CH), 7.22 (ddd; J = 8.3, 7.1, 1.0 Hz; 1 1 H, 6′-CH), 7.19 (s, 1 1 H, 2′-CH), 7.10 (ddd; J = 8.1, 7.0, 1.0 <lb/>Hz; 1 1 H, 5′-CH), 4.43 (dd; J = 9.6, 7.5 Hz; 1 1 H, 4-CH), 3.76 (s, 3 1 H, OCH 3 ), 3.74 (s, 3 1 H, 1′-NCH 3 ), <lb/>3.51 (d, J = 10.2 Hz, 1 1 H, 2-CHH), 3.25 (d, J = 10.2 Hz, 1 1 H, 2-CHH), 3.23 (dd; J = 9.6, 7.5 Hz; 1 <lb/>1 H, 5-CHH), 3.08 (t, J = 9.6 Hz, 1 1 H, 5-CHH), 2.51 (s, 3 1 H, 1-NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), <lb/>CDCl 3 ]: 169.0 (CO 2 ), 136.8 (7′a-C), 127.7 (3′a-C), 127.4 (2′-C), 122.1 (6′-C), 119.5 (5′-C), 118.7 (4′-<lb/>C), 118.5 (CN), 109.63 (3′-C), 109.58 (7′-C), 65.3 (2-C), 60.9 (5-C), 55.1 (3-C), 53.9 (OCH 3 ), 45.2 (4-<lb/>C), 42.0 (1-NCH 3 ), 33.0 (1′-NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3045, 2948, 2842, 2786, 2243, 1741, 1474, <lb/>1243, 742. HRMS [EI (m/z)] calcd for C 17 H 19 N 3 O 2 = 297.1477, found for [M +• ] = 297.1467 (|Δ| = 3.5 <lb/>ppm), peaks at (relative intensity): 297 (17), 144 (16), 57 (100), 42 (21). R F : 0.17 (heptane/AcOEt, <lb/>1:1). Mp: 92.6 °C. Purity: 98.8% (GC). <lb/>(±)-Methyl <lb/>(3R,4R)-3-cyano-4-{1-[(dimethylamino)methyl]-1H-indol-3-yl}-1-methylpyrrolidine-3-<lb/>carboxylate (7{13}): According to the general procedure, 2-cyanoacrylate 8{8} (1.512 g, 6.68 mmol) <lb/>afforded 7{13} (1.929 g, 85%) as a yellow solid. 1 H-NMR [300 MHz, δ (ppm), CDCl 3 ]: 7.45 (d, J = <lb/>7.8 Hz, 1 1 H, 4′-CH), 7.36 (d, J = 8.1 Hz, 1 1 H, 7′-CH), 7.24 (s, 1 1 H, 2′-CH), 7.14 (ddd; J = 8.1, 6.9, <lb/>1.0 Hz; 1 1 H, 6′-CH), 7.05 (ddd; J = 7.8, 6.9, 1.0 Hz; 1 1 H, 5′-CH), 4.69 (d, J = 12.9 Hz, 1 1 H, <lb/>NCHHN), 4.58 (d, J = 12.9 Hz, 1 1 H, NCHHN), 4.40 (dd; J = 9.3, 7.6 Hz; 1 1 H, 4-CH), 3.67 (s, 3 1 H, <lb/>OCH 3 ), 3.43 (d, J = 10.0 Hz, 1 1 H, 2-CHH), 3.17 (d, J = 10.0 Hz, 1 1 H, 2-CHH), 3.16 (dd; J = 9.3, 7.6 <lb/>Hz; 1 1 H, 5-CHH), 3.04 (t, J = 9.3 Hz, 1 1 H, 5-CHH), 2.42 (s, 3 1 H, 1-NCH 3 ), 2.23 (s, 6 1 H, N(CH 3 ) 2 ). <lb/>13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 168.5 (CO 2 ), 136.7 (7′a-C), 127.5 (3′a-C), 126.9 (2′-C), 121.9 <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2286 <lb/></page>

			<body>(6′-C), 119.4 (5′-C), 118.3 (4′-C), 118.0 (CN), 110.21 (3′-C), 110.17 (7′-C), 68.6 (NCH 2 N), 65.3 (2-C), <lb/>60.7 (5-C), 55.1 (3-C), 53.8 (OCH 3 ), 44.8 (4-C), 42.7 (N(CH 3 ) 2 ), 41.8 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: <lb/>3049, 2942, 2842, 2778, 2242, 1740, 1460, 1239, 729. Elem. anal. calcd for C 19 H 24 N 4 O 2 : C 67.04%, H <lb/>7.11%, N 16.46%; found C 66.98%, H 7.05%, N 16.18%. R F : 0.19 (AcOEt). Mp: 105.8 °C. <lb/>(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(2-thienyl)pyrrolidine-3-carboxylate (7{9}): According to the <lb/>general procedure, 2-cyanoacrylate 8{9} (720 mg, 3.73 mmol) afforded 7{9} (814 mg; 87%, combined <lb/>yield including 11{9}) as a yellow oil, after column chromatography (heptane/AcOEt, 1:1). 1 H-NMR <lb/>[300 MHz, δ (ppm), CDCl 3 ]: 7.23 (dd; J = 5.1, 1.0 Hz; 1 1 H, 5′-CH), 7.04 (dt; J = 3.6, 1.0 Hz; 1 1 H, 3′-<lb/>CH), 6.98 (dd; J = 5.1, 3.6 Hz; 1 1 H, 4′-CH), 4.32 (app t, J = 7.8 Hz, 1 1 H, 4-CH), 3.85 (s, 3 1 H, <lb/>OCH 3 ), 3.40 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.24 (dd; J = 9.6, 7.2 Hz; 1 1 H, 5-CHH), 3.17 (d, J = 9.9 <lb/>Hz, 1 1 H, 2-CHH), 3.00 (dd; J = 9.6, 8.4 Hz; 1 1 H, 5-CHH), 2.46 (s, 3 1 H, NCH 3 ). MS [ESI (m/z)] <lb/>calcd for (C 12 H 14 N 2 O 2 S + H) + = 251, found 251. R F : 0.31 (heptane/AcOEt, 1:1). Purity: 97.6% (GC). <lb/>(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(2-pyridyl)pyrrolidine-3-carboxylate (7{10}): According to <lb/>the general procedure, 2-cyanoacrylate 8{10} (1.006 g, 5.35 mmol) afforded a 6.5:1 mixture of <lb/>7{10}/11{10} (1.182 g; 90%, combined yield) as a white solid, after column chromatography <lb/>(CH 2 Cl 2 /MeOH, 24:1). (Measured from a 6.5:1 mixture of 7{10}/11{10}) 1 H-NMR [400 MHz, δ <lb/>(ppm), CDCl 3 ]: 8.61 (d, J = 4.8 Hz, 1 1 H, 6′-CH), 7.68 (app dt; J = 1.8, 7.6 Hz; 1 1 H, 4′-CH), 7.30 (d, J <lb/>= 7.8 Hz, 1 1 H, 3′-CH), 6.91 (ddd; J = 7.6, 4.8, 0.7 Hz; 1 1 H, 5′-CH), 4.30 (t, J = 8.0 Hz, 1 1 H, 4-CH), <lb/>3.88 (s, 3 1 H, OCH 3 ), 3.38 (d, J = 9.6 Hz, 1 1 H, 2-CHH), 3.28 (dd; J = 9.3, 8.0 Hz; 1 1 H, 5-CHH), 3.26 <lb/>(d, J = 9.6 Hz, 1 1 H, 2-CHH), 3.22 (dd; J = 9.3, 8.0 Hz; 1 1 H, 5-CHH), 2.49 (s, 3 1 H, NCH 3 ). MS [ESI <lb/>(m/z)] calcd for (C 13 H 15 N 3 O 2 + H) + = 246, found 246. R F : 0.07 (heptane/AcOEt, 1:1). <lb/>(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(3-pyridyl)pyrrolidine-3-carboxylate (7{11}): According to <lb/>the general procedure, 2-cyanoacrylate 8{11} (2.969 g, 15.78 mmol) afforded a 6.6:1 mixture of <lb/>7{11}/11{11} (2.782 g; 72%, combined yield) as a light yellow sticky solid, after column <lb/>chromatography (CH 2 Cl 2 /MeOH, 29:1). (Measured from a 6.6:1 mixture of 7{11}/11{11}) 1 H-NMR <lb/>[400 MHz, δ (ppm), CDCl 3 ]: 8.56 (dd; J = 4.9, 1.7 Hz; 1 1 H, 6′-CH), 8.56-8.54 (m, 1 1 H, 2′-CH), 7.81 <lb/>(app dt; J = 8.0, 2.0 Hz; 1 1 H, 4′-CH), 7.33 (ddd; J = 8.0, 4.9, 0.5 Hz; 1 1 H, 5′-CH), 4.06 (app t, J = 7.7 <lb/>Hz, 1 1 H, 4-CH), 3.84 (s, 3 1 H, OCH 3 ), 3.32 (d, J = 10.0 Hz, 1 1 H, 2-CHH), 3.28 (d, J = 10.0 Hz, 1 1 H, <lb/>2-CHH), 3.09 (dd; J = 9.5, 7.8 Hz; 1 1 H, 5-CHH), 3.06 (dd; J = 9.5, 7.6 Hz; 1 1 H, 5-CHH), 2.47 (s, 3 <lb/>1 H, NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 168.0 (CO 2 ), 150.1 (2′-C), 149.65 (6′-C), 135.9 (4′-<lb/>C), 133.2 (3′-C), 123.5 (5′-C), 117.6 (CN), 65.1 (2-C), 60.6 (5-C), 54.4 (3-C), 54.1 (CO 2 CH 3 ), 49.4 (4-<lb/>C), 41.3 (NCH 3 ). MS [ESI (m/z)] calcd for (C 13 H 15 N 3 O 2 + H) + = 246, found 246. R F : 0.10 <lb/>(heptane/AcOEt, 1:1). <lb/>(±)-Methyl (3R,4S)-3-cyano-1-methyl-4-(3-pyridyl)pyrrolidine-3-carboxylate (11{11}): According to <lb/>the general procedure, 2-cyanoacrylate 8{11} (2.969 g, 15.78 mmol) afforded a 6.6:1 mixture of <lb/>7{11}/11{11} (2.782 g; 72%, combined yield) as a light yellow sticky solid, after column <lb/>chromatography (CH 2 Cl 2 /MeOH, 29:1). (Measured from a 6.6:1 mixture of 7{11}/11{11}) 1 H-NMR <lb/>[400 MHz, δ (ppm), CDCl 3 ]: 8.56-8.54 (m, 1 1 H, 2′-CH), 8.53 (dd; J = 4.9, 1.7 Hz; 1 1 H, 6′-CH), 7.69 <lb/>(app dt; J = 8.0, 2.0 Hz; 1 1 H, 4′-CH), 7.25 (ddd; J = 8.0, 4.9, 0.5 Hz; 1 1 H, 5′-CH), 4.07-4.04 (m, 1 <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2287 <lb/></page>

			<body>1 H, 4-CH), 3.40 (d, J = 10.2 Hz, 1 1 H, 2-CHH), 3.35 (d, J = 10.2 Hz, 1 1 H, 2-CHH), 3.27 (s, 3 1 H, <lb/>OCH 3 ), 3.09 (dd; J = 9.3, 6.6 Hz; 1 1 H, 5-CHH), 2.97 (dd; J = 9.3, 8.6 Hz; 1 1 H, 5-CHH), 2.51 (s, 3 1 H, <lb/>NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 166.6 (CO 2 ), 150.0 (2′-C), 149.60 (6′-C), 135.9 (4′-C), <lb/>131.9 (3′-C), 123.2 (5′-C), 120.2 (CN), 63.4 (2-C), 59.6 (5-C), 53.4 (4-C), 53.1 (CO 2 CH 3 ), 52.4 (3-C), <lb/>41.2 (NCH 3 ). R F : 0.10 (heptane/AcOEt, 1:1). <lb/>(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(4-pyridyl)pyrrolidine-3-carboxylate (7{12}): According to <lb/>the general procedure, 2-cyanoacrylate 8{12} (1.037 g, 5.51 mmol) afforded a 5:1 mixture of <lb/>7{12}/11{12} (1.145 g; 85%, combined yield) as a light yellow oil, after column chromatography <lb/>(CH 2 Cl 2 /MeOH, 24:1). (Measured from a 5:1 mixture of 7{12}/11{12}) 1 H-NMR [400 MHz, δ (ppm), <lb/>CDCl 3 ]: 8.62-8.58 (m, 2 1 H, 2′-CH + 6′-CH), 7.32-7.28 (m, 2 1 H, 3′-CH + 5′-CH), 4.03 (app t, J = 7.6 <lb/>Hz, 1 1 H, 4-CH), 3.86 (s, 3 1 H, OCH 3 ), 3.32 (d, J = 10.0 Hz, 1 1 H, 2-CHH), 3.26 (d, J = 10.0 Hz, 1 1 H, <lb/>2-CHH), 3.09 (dd; J = 9.8, 7.2 Hz; 1 1 H, 5-CHH), 3.06 (dd; J = 9.8, 7.8 Hz; 1 1 H, 5-CHH), 2.47 (s, 3 <lb/>1 H, NCH 3 ). MS [ESI (m/z)] calcd for (C 13 H 15 N 3 O 2 + H) + = 246, found 246. R F : 0.06 (heptane/AcOEt, <lb/>1:1). <lb/>3.4. General procedure for reduction <lb/>An excess (7-8 heaped teaspoons) of freshly washed (with MeOH) Raney nickel was added to a <lb/>solution of α-cyano ester 7 with Et 3 N (ca. 1 equiv) in MeOH (0.25-0.30 M). The mixture was stirred <lb/>for 15 h at room temperature under a hydrogen atmosphere (1 atm). The catalyst was separated by <lb/>filtration with suction through a glass filter with a 0.5 cm layer of diatomaceous earth. The catalyst <lb/>was washed thoroughly with MeOH. The combined methanolic solutions were concentrated on a <lb/>rotary evaporator. <lb/>(±)-Methyl (3R,4S)-3-(aminomethyl)-1-methyl-4-phenylpyrrolidine-3-carboxylate (6{1}): According to <lb/>the general procedure, α-cyano ester 7{1} (5.040 g, 20.63 mmol) afforded 6{1} (4.858 g, 95%) as a <lb/>colorless oil. 1 H-NMR [200 MHz, δ (ppm), CDCl 3 ]: 7.36-7.21 (m, 5 1 H, Ph), 3.93 (dd; J = 8.6, 7.3 Hz; <lb/>1 1 H, 4-CH), 3.79 (s, 3 1 H, OCH 3 ), 3.35 (d, J = 9.6 Hz, 1 1 H, 2-CHH), 3.08 (dd; J = 9.2, 7.3 Hz; 1 1 H, <lb/>5-CHH), 2.77 (app t, J = 9.0 Hz, 1 1 H, 5-CHH), 2.62 (d, J = 13.0 Hz, 1 1 H, CHHNH 2 ), 2.52 (d, <lb/>J = 13.0 Hz, 1 1 H, CHHNH 2 ), 2.48 (d, J = 9.6 Hz, 1 1 H, 2-CHH), 2.41 (s, 3 1 H, NCH 3 ), 1.78 (bs, 2 1 H, <lb/>NH 2 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 175.9 (CO 2 ), 138.4 (1′-C), 128.7 (2′-C + 6′-C), 127.9 (3′-<lb/>C + 5′-C), 126.6 (4′-C), 64.0 (2-C), 61.6 (5-C), 58.6 (3-C), 52.2 (CO 2 CH 3 ), 49.9 (4-C), 46.7 <lb/>(CH 2 NH 2 ), 42.2 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3386, 3028, 2946, 2781, 1727, 1601, 1455, 1174, 772, <lb/>703. HRMS [ESI (m/z)] calcd for (C 14 H 20 N 2 O 2 + H) + = 249.16030, found 249.15963 (|Δ| = 2.71 ppm). <lb/>R F : 0.30 (CH 2 Cl 2 /MeOH, 8:1). Purity: 99.1% (GC). <lb/>(±)-Methyl (3R,4S)-3-(aminomethyl)-4-(4-methoxyphenyl)-1-methylpyrrolidine-3-carboxylate (6{2}): <lb/>According to the general procedure, α-cyano ester 7{2} (6.997 g, 25.51 mmol) afforded 6{2} (6.731 g, <lb/>95%) as a colorless oil. 1 H-NMR [400 MHz, δ (ppm), CDCl 3 ]: 7.27-7.23 (m, 2 1 H, 2′-CH + 6′-CH), <lb/>6.86-6.82 (m, 2 1 H, 3′-CH + 5′-CH), 3.88 (app t, J = 8.0 Hz, 1 1 H, 4-CH), 3.79 (s, 3 1 H, CO 2 CH 3 ), 3.78 <lb/>(s, 3 1 H, OCH 3 ), 3.33 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.06 (dd; J = 8.8, 7.8 Hz; 1 1 H, 5-CHH), 2.71 (app <lb/>t, J = 8.9 Hz, 1 1 H, 5-CHH), 2.63 (d, J = 13.2 Hz, 1 1 H, CHHNH 2 ), 2.52 (d, J = 13.2 Hz, 1 1 H, <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2288 <lb/></page>

			<body>CHHNH 2 ), 2.46 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 2.40 (s, 3 1 H, NCH 3 ), 0.92 (bs, 2 1 H, NH 2 ). 13 C-NMR <lb/>[75 MHz, δ (ppm), CDCl 3 ]: 176.1 (CO 2 ), 158.2 (4′-C), 130.3 (1′-C), 129.7 (2′-C + 6′-C), 113.5 (3′-C + <lb/>5′-C), 64.1 (2-C), 61.8 (5-C), 58.6 (3-C), 55.2 (OCH 3 ), 52.3 (CO 2 CH 3 ), 49.2 (4-C), 46.8 (CH 2 NH 2 ), <lb/>42.3 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3383, 3222, 2947, 2834, 2779, 1724, 1247, 834. HRMS [ESI <lb/>(m/z)] calcd for (C 15 H 22 N 2 O 3 + H) + = 279.17087, found 279.17006 (|Δ| = 2.87 ppm). R F : 0.27 <lb/>(CH 2 Cl 2 /MeOH, 8:1). Purity: 98.1% (GC). <lb/>(±)-Methyl <lb/>(3R,4S)-3-(aminomethyl)-4-(3,5-dimethoxyphenyl)-1-methylpyrrolidine-3-carboxylate <lb/>(6{3}): According to the general procedure, α-cyano ester 7{3} (7.452 g, 25.06 mmol) afforded 6{3} <lb/>(6.730 g, 89%) as a yellow oil, after column chromatography (CH 2 Cl 2 /MeOH, 9:1). 1 H-NMR [400 <lb/>MHz, δ (ppm), CDCl 3 ]: 6.51 (d, J = 2.2 Hz, 2 1 H, 2′-CH + 6′-CH), 6.35 (t, J = 2.2 Hz, 1 1 H, 4′-CH), <lb/>3.87 (app t, J = 7.9 Hz, 1 1 H, 4-CH), 3.80 (s, 3 1 H, CO 2 CH 3 ), 3.78 (s, 6 1 H, 2 × OCH 3 ), 3.31 (d, J = 9.8 <lb/>Hz, 1 1 H, 2-CHH), 3.06 (dd; J = 9.0, 7.8 Hz; 1 1 H, 5-CHH), 2.72 (app t, J = 8.8 Hz, 1 1 H, 5-CHH), <lb/>2.71 (d, J = 13.0 Hz, 1 1 H, CHHNH 2 ), 2.58 (d, J = 13.0 Hz, 1 1 H, CHHNH 2 ), 2.48 (d, J = 9.8 Hz, 1 1 H, <lb/>2-CHH), 2.40 (s, 3 1 H, NCH 3 ), 1.45 (bs, 2 1 H, NH 2 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 176.5 <lb/>(CO 2 ), 160.6 (3′-C + 5′-C), 141.2 (1′-C), 107.5 (2′-C + 6′-C), 98.6 (4′-C), 64.2 (2-C), 61.6 (5-C), 58.7 <lb/>(3-C), 55.3 (2 × OCH 3 ), 52.4 (CO 2 CH 3 ), 50.0 (4-C), 46.6 (CH 2 NH 2 ), 42.3 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), <lb/>neat]: 3380, 3188, 2942, 2835, 2781, 1723, 1593, 1203, 1152. HRMS [ESI (m/z)] calcd for <lb/>(C 16 H 24 N 2 O 4 + H) + = 309.18143, found 309.18062 (|Δ| = 2.62 ppm). R F : 0.30 (CH 2 Cl 2 /MeOH, 8:1). <lb/>Purity: 98.2% (GC). <lb/>(±)-Methyl <lb/>(3R,4S)-3-(aminomethyl)-4-(1,3-benzodioxol-5-yl)-1-methylpyrrolidine-3-carboxylate <lb/>(6{4}): According to the general procedure, α-cyano ester 7{4} (7.009 g, 24.31 mmol) afforded 6{4} <lb/>(6.055 g, 85%) as a light yellow oil, after column chromatography (CH 2 Cl 2 /MeOH, 9:1). 1 H-NMR <lb/>[400 MHz, δ (ppm), CDCl 3 ]: 6.88 (d, J = 1.7 Hz, 1 1 H, 4′-CH), 6.78 (dd; J = 8.1, 1.5 Hz; 1 1 H, 6′-CH), <lb/>6.72 (d, J = 8.1 Hz, 1 1 H, 7′-CH), 5.92 (s, 2 1 H, 2′-CH 2 ), 3.83 (app t, J = 7.7 Hz, 1 1 H, 4-CH), 3.78 (s, 3 <lb/>1 H, OCH 3 ), 3.27 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.01 (dd; J = 9.3, 7.6 Hz; 1 1 H, 5-CHH), 2.67 (app t, J <lb/>= 8.7 Hz, 1 1 H, 5-CHH), 2.66 (d, J = 12.9 Hz, 1 1 H, CHHNH 2 ), 2.53 (d, J = 12.9 Hz, 1 1 H, CHHNH 2 ), <lb/>2.48 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 2.38 (s, 3 1 H, NCH 3 ), 1.01 (bs, 2 1 H, NH 2 ). 13 C-NMR [75 MHz, δ <lb/>(ppm), CDCl 3 ]: 176.3 (CO 2 ), 147.4 (3′a-C), 146.3 (7′a-C), 132.5 (5′-C), 122.0 (6′-C), 109.3 (4′-C), <lb/>107.8 (7′-C), 100.8 (2′-C), 63.8 (2-C), 61.8 (5-C), 58.6 (3-C), 52.1 (OCH 3 ), 49.5 (4-C), 46.6 <lb/>(CH 2 NH 2 ), 42.0 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3320, 3317, 2946, 2841, 2776, 1721, 1248, 1232, <lb/>1034, 929. HRMS [ESI (m/z)] calcd for (C 15 H 20 N 2 O 4 + H) + = 293.15013, found 293.14936 (|Δ| = 2.63 <lb/>ppm). R F : 0.25 (CH 2 Cl 2 /MeOH, 8:1). Purity: 97.4% (GC). <lb/>(±)-Methyl (3R,4S)-3-(aminomethyl)-1-methyl-4-(1-methyl-1H-pyrrol-2-yl)pyrrolidine-3-carboxylate <lb/>(6{5}): According to the general procedure, α-cyano ester 7{5} (752 mg, 3.04 mmol) afforded 6{5} <lb/>(559 mg, 73%) as a light yellow oil, after column chromatography (CH 2 Cl 2 /MeOH, 9:1). 1 H-NMR <lb/>[400 MHz, δ (ppm), CDCl 3 ]: 6.54 (dd; J = 2.4, 1.8 Hz; 1 1 H, 5′-CH), 6.07 (dd; J = 3.6, 2.7 Hz; 1 1 H, <lb/>4′-CH), 6.04 (dd; J = 3.8, 1.7 Hz; 1 1 H, 3′-CH), 4.10 (dd; J = 10.5, 7.2 Hz; 1 1 H, 4-CH), 3.78 (s, 3 1 H, <lb/>OCH 3 ), 3.60 (s, 3 1 H, 1′-NCH 3 ), 3.39 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 3.19 (app t, J = 8.2 Hz, 1 1 H, 5-<lb/>CHH), 2.72 (d, J = 13.2 Hz, 1 1 H, CHHNH 2 ), 2.62 (d, J = 13.2 Hz, 1 1 H, CHHNH 2 ), 2.47 (app t, <lb/>J = 9.8 Hz, 1 1 H, 5-CHH), 2.35 (s, 3 1 H, 1-NCH 3 ), 2.21 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 1.35 (bs, 2 1 H, <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2289 <lb/></page>

			<body>NH 2 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 177.1 (CO 2 ), 129.8 (2′-C), 122.3 (5′-C), 107.8 (3′-C), <lb/>107.3 (4′-C), 65.3 (2-C), 62.5 (5-C), 58.4 (3-C), 52.5 (OCH 3 ), 46.7 (CH 2 NH 2 ), 42.2 (1-NCH 3 ), 40.9 (4-<lb/>C), 34.2 (1′-NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3390, 3099, 2946, 2839, 2780, 1729, 1242, 712. HRMS <lb/>[ESI (m/z)] calcd for (C 13 H 21 N 3 O 2 + H) + = 252.17120, found 252.17083 (|Δ| = 1.49 ppm). R F : 0.24 <lb/>(CH 2 Cl 2 /MeOH, 8:1). Purity: 97.7% (GC). <lb/>(±)-Methyl <lb/>(3R,4S)-3-(aminomethyl)-1-methyl-4-(1-methyl-1H-indol-3-yl)pyrrolidine-3-carboxylate <lb/>(6{6}): According to the general procedure, α-cyano ester 7{6} (7.628 g, 25.65 mmol) afforded 6{6} <lb/>(7.337 g, 95%) as a yellow oil, after column chromatography (CH 2 Cl 2 /MeOH, 9:1). 1 H-NMR [400 <lb/>MHz, δ (ppm), CDCl 3 ]: 7.72 (dt; J = 8.0, 1.0 Hz; 1 1 H, 4′-CH), 7.28 (dt; J = 8.0, 1.0 Hz; 1 1 H, 7′-CH), <lb/>7.21 (ddd; J = 8.0, 6.8, 1.0 Hz; 1 1 H, 6′-CH), 7.11 (ddd; J = 8.0, 6.8, 1.0 Hz; 1 1 H, 5′-CH), 6.98 (s, 1 <lb/>1 H, 2′-CH), 4.32 (dd; J = 9.3, 7.3 Hz; 1 1 H, 4-CH), 3.83 (s, 3 1 H, OCH 3 ), 3.76 (s, 3 1 H, 1′-NCH 3 ), 3.43 <lb/>(d, J = 10.0 Hz, 1 1 H, 2-CHH), 3.17 (dd; J = 9.3, 7.3 Hz; 1 1 H, 5-CHH), 2.75 (d, J = 13.2 Hz, 1 1 H, <lb/>CHHNH 2 ), 2.68 (t, J = 9.3 Hz, 1 1 H, 5-CHH), 2.60 (d, J = 13.2 Hz, 1 1 H, CHHNH 2 ), 2.45 (d, J = 10.0 <lb/>Hz, 1 1 H, 2-CHH), 2.42 (s, 3 1 H, 1-NCH 3 ), 1.04 (bs, 2 1 H, NH 2 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: <lb/>177.1 (CO 2 ), 136.9 (7′a-C), 128.3 (3′a-C), 127.3 (2′-C), 122.0 (6′-C), 119.9 (5′-C), 119.3 (4′-C), 112.0 <lb/>(3′-C), 109.3 (7′-C), 64.8 (2-C), 62.5 (5-C), 58.4 (3-C), 52.4 (OCH 3 ), 47.1 (CH 2 NH 2 ), 42.5 (4-C), 41.6 <lb/>(1-NCH 3 ), 32.9 (1′-NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3386, 3047, 2946, 2834, 2779, 1720, 1472, 1172, <lb/>741. HRMS [EI (m/z)] calcd for C 17 H 23 N 3 O 2 = 301.1790, found for [M +• ] = 301.1776 (|Δ| = 4.7 ppm), <lb/>peaks at (relative intensity): 301 (7), 284 (93), 228 (18), 157 (100), 144 (22), 57 (27). R F : 0.22 <lb/>(CH 2 Cl 2 /MeOH, 8:1). Purity: 98.0% (GC). <lb/>(±)-(3R,4R)-3-Cyano-1-methyl-4-phenylpyrrolidine-3-carboxamide (12{1}): 1 H-NMR [300 MHz, δ <lb/>(ppm), CDCl 3 ]: 7.41-7.26 (m, 5 1 H, Ph), 6.58 (s, 1 1 H, NHH), 6.40 (s, 1 1 H, NHH), 3.99 (app t, J = 8.1 <lb/>Hz, 1 1 H, 4-CH), 3.34 (d, J = 9.8 Hz, 1 1 H, 2-CHH), 3.16 (app t, J = 8.7 Hz, 1 1 H, 5-CHH), 3.12 (d, <lb/>J = 9.8 Hz, 1 1 H, 2-CHH), 3.03 (app t, J = 8.9 Hz, 1 1 H, 5-CHH), 2.47 (s, 3 1 H, NCH 3 ). 13 C-NMR [75 <lb/>MHz, δ (ppm), CDCl 3 ]: 169.4 (CON), 137.1 (1′-C), 128.6 (2′-C + 6′-C), 128.4 (3′-C + 5′-C), 128.2 (4′-<lb/>C), 119.0 (CN), 65.2 (2-C), 60.9 (5-C), 55.9 (3-C), 53.1 (4-C), 41.6 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: <lb/>3334, 3192, 2950, 2846, 2794, 2241, 1684, 772, 698. Elem. anal. calcd for C 13 H 15 N 3 O: C 68.11%, H <lb/>6.59%, N 18.33%; found C 68.10%, H 6.48%, N 18.13%. R F : 0.40 (AcOEt). Mp: 121.7 °C (from <lb/>propan-2-ol, small white needles). Purity: &gt;99.5% (GC). <lb/>3.5. Parallel synthesis <lb/>3.5.1. General procedure 1 for spiro dihydrouracil/α-ureidomethyl acid formation using parallel <lb/>synthesis <lb/>A solution of isocyanate 13 (0.12 mmol for 1, 0.10 mmol for 3-5) from a 0.3 M stock solution in <lb/>CH 2 Cl 2 was added to a solution of α-aminomethyl ester (0.10 mmol) in CH 2 Cl 2 (1.5 mL). The <lb/>resulting reaction mixture was stirred at room temperature for 15 h. After that time, the solvent was <lb/>evaporated and THF (1.5 mL) and 1 M KOBu t in THF (0.10 mmol) were added. The reaction mixture <lb/>was then stirred at room temperature for 15 h. A saturated solution of NH 4 Cl (1.0 mL) was added and <lb/>the layers were separated (centrifugation was needed for the separation when aryl isocyanate was <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2290 <lb/></page>

			<body>used). The aqueous layer was extracted with CH 2 Cl 2 (2 × 1.5 mL) and the combined organic layers <lb/>were evaporated to dryness under vacuum. <lb/>3.5.2. General procedure 2 for spiro dihydrouracil/α-ureidomethyl acid formation using parallel <lb/>synthesis <lb/>A solution of isocyanate 13{2,6-8} (0.10 mmol) from a 0.3 M stock solution in DMF was added to <lb/>a solution of α-aminomethyl ester (0.10 mmol) in DMF (1.5 mL). The resulting reaction mixture was <lb/>stirred at 80 °C for 15 h. After that time, the solvent was evaporated and THF (1.5 mL) and 1 M <lb/>KOBu t in THF (0.10 mmol) were added. The reaction mixture was then stirred at room temperature for <lb/>15 h. A saturated solution of NH 4 Cl (1.0 mL) was added and the layers were separated (centrifugation <lb/>was needed for the separation when aryl isocyanate was used). The aqueous layer was extracted with <lb/>CH 2 Cl 2 (2 × 1.5 mL) and the combined organic layers were evaporated to dryness under vacuum. <lb/>(±)-(4R,5S)-7-Ethyl-2-methyl-4-phenyl-2,7,9-triazaspiro[4.5]decane-6,8-dione (5{1,1}): (From 6{1}) <lb/>1 H-NMR [400 MHz, δ (ppm), CDCl 3 ]: 7.30-7.19 (m, 5 1 H, Ph), 5.60 (bd, J = 2.1 Hz, 1 1 H, NH), 4.20 <lb/>(dd; J = 8.1, 5.4 Hz; 1 1 H, 4-CH), 3.85 (dq; J = 12.9, 7.2 Hz; 1 1 H, CHHCH 3 ), 3.80 (dq; J = 12.9, 7.2 <lb/>Hz; 1 1 H, CHHCH 3 ), 3.06 (dd; J = 9.6, 5.4 Hz; 1 1 H, 3-CHH), 2.99 (dd; J = 9.6, 8.1 Hz; 1 1 H, 3-CHH), <lb/>2.95 (d, J = 9.3 Hz, 1 1 H, 1-CHH), 2.94 (dd; J = 12.6, 4.2 Hz; 1 1 H, 10-CHH), 2.68 (d, J = 9.3 Hz, 1 <lb/>1 H, 1-CHH), 2.66 (d, J = 12.6 Hz, 1 1 H, 10-CHH), 2.41 (s, 3 1 H, NCH 3 ), 1.16 (t, J = 7.2 Hz, 3 1 H, <lb/>CH 2 CH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 173.1 (6-C), 154.1 (8-C), 139.4 (1′-C), 128.7 (2′-C + <lb/>6′-C), 128.6 (3′-C + 5′-C), 127.3 (4′-C), 64.0 (1-C), 62.0 (3-C), 52.0 (5-C), 48.3 (4-C), 43.4 (10-C), <lb/>42.0 (NCH 3 ), 36.4 (CH 2 CH 3 ), 13.8 (CH 2 CH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3240, 2937, 2841, 2784, 1716, <lb/>1673, 763, 703. MS [APCI (m/z)] calcd for (C 16 H 21 N 3 O 2 + H) + = 288, found 288. Crude yield: 51%. <lb/>Purity: 89% (LC). <lb/>(±)-(4R,5S)-2-Methyl-7-phenethyl-4-phenyl-2,7,9-triazaspiro[4.5]decane-6,8-dione (5{1,2}): (From <lb/>6{1}) 1 H-NMR [400 MHz, δ (ppm), CDCl 3 ]: 7.33-7.15 (m, 10 1 H, 2 × Ph), 5.66 (bd, J = 3.4 Hz, 1 1 H, <lb/>NH), 4.16 (dd; J = 8.0, 5.4 Hz; 1 1 H, 4-CH), 4.04 (dt; J = 13.0, 7.6 Hz; 1 1 H, NCHHCH 2 ), 3.98 (dt; J = <lb/>13.0, 7.6 Hz; 1 1 H, NCHHCH 2 ), 3.05 (dd; J = 9.3, 5.4 Hz; 1 1 H, 3-CHH), 2.98-2.83 (m, 5 1 H, 1-CHH <lb/>+ 3-CHH + 10-CHH + NCH 2 CH 2 ), 2.56 (d, J = 9.5 Hz, 1 1 H, 1-CHH), 2.55 (d, J = 13.2 Hz, 1 1 H, 10-<lb/>CHH), 2.39 (s, 3 1 H, NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 173.2 (6-C), 154.0 (8-C), 139.3 <lb/>(1′′-C), 138.6 (1′-C), 129.2 (2′-C + 6′-C), 128.8 (2′′-C + 6′′-C), 128.6 (3′′-C + 5′′-C), 128.5 (3′-C + 5′-<lb/>C), 127.3 (4′′-C), 126.5 (4′-C), 64.0 (1-C), 61.9 (3-C), 52.1 (5-C), 48.2 (4-C), 43.4 (10-C), 42.2 <lb/>(NCH 2 CH 2 ), 41.9 (NCH 3 ), 34.5 (NCH 2 CH 2 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3254, 2938, 2841, 2784, 1717, <lb/>1673, 758, 701. MS [APCI (m/z)] calcd for (C 22 H 25 N 3 O 2 + H) + = 364, found 364. Crude yield: 63%. <lb/>Purity: 70% (LC). <lb/>(±)-Ethyl <lb/>3-{(4R,5S)-2-methyl-6,8-dioxo-4-phenyl-2,7,9-triazaspiro[4.5]decan-7-yl}propanoate <lb/>(5{1,3}): (From 6{1}) MS [APCI (m/z)] calcd for (C 19 H 25 N 3 O 4 + H) + = 360, found 360. Crude yield: <lb/>80% (combined yield of 5{1,3}, 5{1,9}, 5{1,10}, and 5{1,11}). Purity: 91% (LC; combined purity of <lb/>5{1,3}, 5{1,9}, 5{1,10}, and 5{1,11}). <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2291 <lb/></page>

			<body>(±)-(4R,5S)-7-Ethyl-4-(4-methoxyphenyl)-2-methyl-2,7,9-triazaspiro[4.5]decane-6,8-dione (5{2,1}): <lb/>(From 6{2}) MS [APCI (m/z)] calcd for (C 17 H 23 N 3 O 3 + H) + = 318, found 318. Crude yield: 60%. <lb/>Purity: 93% (LC). <lb/>(±)-(4R,5S)-4-(4-Methoxyphenyl)-2-methyl-7-phenethyl-2,7,9-triazaspiro[4.5]decane-6,8-dione <lb/>(5{2,2}): (From 6{2}) MS [APCI (m/z)] calcd for (C 23 H 27 N 3 O 3 + H) + = 394, found 394. Crude yield: <lb/>64%. Purity: 60% (LC). <lb/>(±)-Ethyl 3-{(4R,5S)-4-(4-methoxyphenyl)-2-methyl-6,8-dioxo-2,7,9-triazaspiro[4.5]decan-7-yl}prop-<lb/>anoate (5{2,3}): (From 6{2}) FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3245, 2935, 2837, 2784, 1719, 1674, 1247, 835. <lb/>MS [APCI (m/z)] calcd for (C 20 H 27 N 3 O 5 + H) + = 390, found 390. Crude yield: 49% (combined yield of <lb/>5{2,3}, 5{2,9}, 5{2,10}, and 5{2,11}). Purity: 88% (LC; combined purity of 5{2,3}, 5{2,9}, 5{2,10}, <lb/>and 5{2,11}). <lb/>(±)-(4R,5S)-4-(3,5-Dimethoxyphenyl)-7-ethyl-2-methyl-2,7,9-triazaspiro[4.5]decane-6,8-dione 5{3,1}): <lb/>(From 6{3}) MS [APCI (m/z)] calcd for (C 18 H 25 N 3 O 4 + H) + = 348, found 348. Crude yield: 66%. <lb/>Purity: 90% (LC). <lb/>(±)-(4R,5S)-4-(3,5-Dimethoxyphenyl)-2-methyl-7-phenethyl-2,7,9-triazaspiro[4.5]decane-6,8-dione <lb/>5{3,2}): (From 6{3}) MS [APCI (m/z)] calcd for (C 24 H 29 N 3 O 4 + H) + = 424, found 424. Crude yield: <lb/>60%. Purity: 68% (LC). <lb/>(±)-Ethyl 3-{(4R,5S)-4-(3,5-dimethoxyphenyl)-2-methyl-6,8-dioxo-2,7,9-triazaspiro[4.5]decan-7-yl}-<lb/>propanoate (5{3,3}): (From 6{3}) MS [APCI (m/z)] calcd for (C 21 H 29 N 3 O 6 + H) + = 420, found 420. <lb/>Crude yield: 54% (combined yield of 5{3,3}, 5{3,9}, 5{3,10}, and 5{3,11}). Purity: 95% (LC; <lb/>combined purity of 5{3,3}, 5{3,9}, 5{3,10}, and 5{3,11}). <lb/>(±)-(4R,5S)-4-(1,3-Benzodioxol-5-yl)-7-ethyl-2-methyl-2,7,9-triazaspiro[4.5]decane-6,8-dione <lb/>(5{4,1}): (From 6{4}) MS [APCI (m/z)] calcd for (C 17 H 21 N 3 O 4 + H) + = 332, found 332. Crude yield: <lb/>63%. Purity: 95% (LC). <lb/>(±)-(4R,5S)-4-(1,3-Benzodioxol-5-yl)-2-methyl-7-phenethyl-2,7,9-triazaspiro[4.5]decane-6,8-dione <lb/>5{4,2}): (From 6{4}) MS [APCI (m/z)] calcd for (C 23 H 25 N 3 O 4 + H) + = 408, found 408. Crude yield: <lb/>64%. Purity: 68% (LC). <lb/>(±)-Ethyl 3-{(4R,5S)-4-(1,3-benzodioxol-5-yl)-2-methyl-6,8-dioxo-2,7,9-triazaspiro[4.5]decan-7-yl}-<lb/>propanoate (5{4,3}): (From 6{4}) MS [APCI (m/z)] calcd for (C 20 H 25 N 3 O 6 + H) + = 404, found 404. <lb/>Crude yield: 61% (combined yield of 5{4,3}, 5{4,9}, 5{4,10}, and 5{4,11}). Purity: 98% (LC; <lb/>combined purity of 5{4,3}, 5{4,9}, 5{4,10}, and 5{4,11}). <lb/>(±)-(4R,5S)-7-Ethyl-2-methyl-4-(1-methyl-1H-pyrrol-2-yl)-2,7,9-triazaspiro[4.5]decane-6,8-dione <lb/>(5{5,1}): (From 6{5}) 1 H-NMR [400 MHz, δ (ppm), CDCl 3 ]: 6.52 (dd; J = 2.8, 1.6 Hz; 1 1 H, 5′-CH), <lb/>6.05 (dd; J = 3.5, 2.8 Hz; 1 1 H, 4′-CH), 6.03 (dd; J = 3.5, 1.6 Hz; 1 1 H, 3′-CH), 5.84 (bd, J = 3.5 Hz, 1 <lb/>1 H, NH), 4.35 (app t, J = 8.0 Hz, 1 1 H, 4-CH), 3.85 (dq; J = 13.1, 7.0 Hz; 1 1 H, CHHCH 3 ), 3.79 (dq; J <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2292 <lb/></page>

			<body>= 13.1, 7.0 Hz; 1 1 H, CHHCH 3 ), 3.44 (s, 3 1 H, 1′-NCH 3 ), 3.15 (app t, J = 8.6 Hz, 1 1 H, 3-CHH), 2.96 <lb/>(dd; J = 13.0, 4.6 Hz; 1 1 H, 10-CHH), 2.92 (d, J = 9.8 Hz, 1 1 H, 1-CHH), 2.78 (app t, J = 8.8 Hz, 1 1 H, <lb/>3-CHH), 2.65 (d, J = 9.8 Hz, 1 1 H, 1-CHH), 2.62 (d, J = 13.0 Hz, 1 1 H, 10-CHH), 2.37 (s, 3 1 H, 2-<lb/>NCH 3 ), 1.15 (t, J = 7.0 Hz, 3 1 H, CH 2 CH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 173.5 (6-C), 154.2 <lb/>(8-C), 129.9 (2′-C), 122.4 (5′-C), 107.5 (3′-C), 107.2 (4′-C), 66.0 (1-C), 62.0 (3-C), 51.0 (5-C), 43.9 <lb/>(10-C), 41.9 (2-NCH 3 ), 39.5 (4-C), 36.4 (CH 2 CH 3 ), 34.1 (1′-NCH 3 ), 13.7 (CH 2 CH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), <lb/>neat]: 3329, 2937, 2842, 2784, 1716, 1671, 727. MS [APCI (m/z)] calcd for (C 15 H 22 N 4 O 2 + H) + = 291, <lb/>found 291. Crude yield: 61%. Purity: 99% (LC). <lb/>(±)-(4R,5S)-2-Methyl-4-(1-methyl-1H-pyrrol-2-yl)-7-phenethyl-2,7,9-triazaspiro[4.5]decane-6,8-dione <lb/>(5{5,2}): (From 6{5}) 1 H-NMR [400 MHz, δ (ppm), CDCl 3 ]: 7.32-7.15 (m, 5 1 H, Ph), 6.51 (dd; J = <lb/>2.8, 1.6 Hz; 1 1 H, 5′-CH), 6.05 (dd; J = 3.5, 2.8 Hz; 1 1 H, 4′-CH), 6.02 (dd; J = 3.5, 1.6 Hz; 1 1 H, 3′-<lb/>CH), 5.96 (bd, J = 4.0 Hz, 1 1 H, NH), 4.31 (app t, J = 8.1 Hz, 1 1 H, 4-CH), 4.08-3.95 (m, 2 1 H, <lb/>NCH 2 CH 2 ), 3.34 (s, 3 1 H, 1′-NCH 3 ), 3.13 (app t, J = 8.6 Hz, 1 1 H, 3-CHH), 2.92 (dd; J = 12.9, 4.7 Hz; <lb/>1 1 H, 10-CHH), 2.91-2.83 (m, 2 1 H, NCH 2 CH 2 ), 2.80 (d, J = 9.8 Hz, 1 1 H, 1-CHH), 2.76 (app t, J = <lb/>8.8 Hz, 1 1 H, 3-CHH), 2.62 (d, J = 9.8 Hz, 1 1 H, 1-CHH), 2.55 (d, J = 12.9 Hz, 1 1 H, 10-CHH), 2.35 <lb/>(s, 3 1 H, 2-NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 173.6 (6-C), 154.2 (8-C), 138.6 (1′′-C), <lb/>129.8 (2′-C), 129.2 (2′′-C + 6′′-C), 128.5 (3′′-C + 5′′-C), 126.5 (4′′-C), 122.4 (5′-C), 107.5 (3′-C), 107.2 <lb/>(4′-C), 65.9 (1-C), 62.0 (3-C), 51.0 (5-C), 43.8 (10-C), 42.2 (NCH 2 CH 2 ), 41.9 (2-NCH 3 ), 39.3 (4-C), <lb/>34.4 (NCH 2 CH 2 ), 34.1 (1′-NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3251, 2941, 2843, 2785, 1716, 1671, 761, <lb/>728, 699. MS [APCI (m/z)] calcd for (C 21 H 26 N 4 O 2 + H) + = 367, found 367. Crude yield: 54%. Purity: <lb/>92% (LC). <lb/>(±)-Ethyl 3-{(4R,5S)-2-methyl-4-(1-methyl-1H-pyrrol-2-yl)-6,8-dioxo-2,7,9-triazaspiro[4.5]decan-7-<lb/>yl}propanoate (5{5,3}): (From 6{5}) MS [APCI (m/z)] calcd for (C 18 H 26 N 4 O 4 + H) + = 363, found 363. <lb/>Crude yield: 66% (combined yield of 5{5,3}, 5{5,9}, 5{5,10}, and 5{5,11}). Purity: 79% (LC; <lb/>combined purity of 5{5,3}, 5{5,9}, 5{5,10}, and 5{5,11}). <lb/>(±)-(4R,5S)-7-Ethyl-2-methyl-4-(1-methyl-1H-indol-3-yl)-2,7,9-triazaspiro[4.5]decane-6,8-dione <lb/>(5{6,1}): (From 6{6}) MS [APCI (m/z)] calcd for (C 19 H 24 N 4 O 2 + H) + = 341, found 341. Crude yield: <lb/>69%. Purity: 69% (LC). <lb/>(±)-(4R,5S)-2-Methyl-4-(1-methyl-1H-indol-3-yl)-7-phenethyl-2,7,9-triazaspiro[4.5]decane-6,8-dione <lb/>(5{6,2}): (From 6{6}) MS [APCI (m/z)] calcd for (C 25 H 28 N 4 O 2 + H)+ = 417, found 417. Crude yield: <lb/>68%. Purity: 62% (LC). <lb/>(±)-Ethyl <lb/>3-{(4R,5S)-2-methyl-4-(1-methyl-1H-indol-3-yl)-6,8-dioxo-2,7,9-triazaspiro[4.5]decan-7-<lb/>yl}-propanoate (5{6,3}): (From 6{6}) MS [APCI (m/z)] calcd for (C 22 H 28 N 4 O 4 + H) + = 413, found <lb/>413. Crude yield: 62% (combined yield of 5{6,3}, 5{6,9}, 5{6,10}, and 5{6,11}). Purity: 86% (LC; <lb/>combined purity of 5{6,3}, 5{6,9}, 5{6,10}, and 5{6,11}). <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2293 <lb/></page>

			<body>(±)-(3R,4S)-1-Methyl-4-phenyl-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylic acid (14{1,4}): <lb/>(From 6{1}) MS [APCI (m/z)] calcd for (C 20 H 23 N 3 O 3 + H) + = 354, found 354. Crude yield: 49%. <lb/>Purity: &gt;99% (LC). <lb/>(±)-(3R,4S)-1-Methyl-4-phenyl-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)pyrrolidine-3-carboxy-<lb/>lic acid (14{1,5}): (From 6{1}) MS [APCI (m/z)] calcd for (C 21 H 22 F 3 N 3 O 3 + H) + = 422, found 422. <lb/>Crude yield: 75%. Purity: 97% (LC). <lb/>(±)-(3R,4S)-3-{[3-(4-Ethoxyphenyl)ureido]methyl}-1-methyl-4-phenylpyrrolidine-3-carboxylic <lb/>acid <lb/>(14{1,6}): (From 6{1}) MS [APCI (m/z)] calcd for (C 22 H 27 N 3 O 4 + H) + = 398, found 398. Crude yield: <lb/>48%. Purity: &gt;99% (LC). <lb/>(±)-(3R,4S)-3-{[3-(3-Cyanophenyl)ureido]methyl}-1-methyl-4-phenylpyrrolidine-3-carboxylic <lb/>acid <lb/>(14{1,7}): (From 6{1}) MS [APCI (m/z)] calcd for (C 21 H 22 N 4 O 3 + H) + = 379, found 379. Crude yield: <lb/>54%. Purity: &gt;99% (LC). <lb/>(±)-(3R,4S)-1-Methyl-4-phenyl-3-{[3-(3-pyridyl)ureido]methyl}pyrrolidine-3-carboxylic <lb/>acid <lb/>(14{1,8}): (From 6{1}) MS [APCI (m/z)] calcd for (C 19 H 22 N 4 O 3 + H) + = 355, found 355. Crude yield: <lb/>49%. Purity: 79% (LC). <lb/>(±)-(3R,4S)-4-(4-Methoxyphenyl)-1-methyl-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylic acid <lb/>(14{2,4}): (From 6{2}) MS [APCI (m/z)] calcd for (C 21 H 25 N 3 O 4 + H) + = 384, found 384. Crude yield: <lb/>60%. Purity: 99% (LC). <lb/>(±)-(3R,4S)-4-(4-Methoxyphenyl)-1-methyl-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)-pyrroli-<lb/>dine-3-carboxylic acid (14{2,5}): (From 6{2}) MS [APCI (m/z)] calcd for (C 22 H 24 F 3 N 3 O 4 + H) + = <lb/>452, found 452. Crude yield: 65%. Purity: 98% (LC). <lb/>(±)-(3R,4S)-3-{[3-(4-Ethoxyphenyl)ureido]methyl}-4-(4-methoxyphenyl)-1-methylpyrrolidine-3-car-<lb/>boxylic acid (14{2,6}): (From 6{2}) MS [APCI (m/z)] calcd for (C 23 H 29 N 3 O 5 + H) + = 428, found 428. <lb/>Crude yield: 70%. Purity: &gt;99% (LC). <lb/>(±)-(3R,4S)-3-{[3-(3-Cyanophenyl)ureido]methyl}-4-(4-methoxyphenyl)-1-methylpyrrolidine-3-car-<lb/>boxylic acid (14{2,7}): (From 6{2}) MS [APCI (m/z)] calcd for (C 22 H 24 N 4 O 4 + H) + = 409, found 409. <lb/>Crude yield: 60%. Purity: 96% (LC). <lb/>(±)-(3R,4S)-4-(4-Methoxyphenyl)-1-methyl-3-{[3-(3-pyridyl)ureido]methyl}pyrrolidine-3-carboxylic <lb/>acid (14{2,8}): (From 6{2}) MS [APCI (m/z)] calcd for (C 20 H 24 N 4 O 4 + H) + = 385, found 385. Crude <lb/>yield: 45%. Purity: 76% (LC). <lb/>(±)-(3R,4S)-4-(3,5-Dimethoxyphenyl)-1-methyl-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylic <lb/>acid (14{3,4}): (From 6{3}) MS [APCI (m/z)] calcd for (C 22 H 27 N 3 O 5 + H) + = 414, found 414. Crude <lb/>yield: 76%. Purity: 97% (LC). <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2294 <lb/></page>

			<body>(±)-(3R,4S)-4-(3,5-Dimethoxyphenyl)-1-methyl-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)pyrro-<lb/>lidine-3-carboxylic acid (14{3,5}): (From 6{3}) MS [APCI (m/z)] calcd for (C 23 H 26 F 3 N 3 O 5 + H) + = <lb/>482, found 482. Crude yield: 63%. Purity: 99% (LC). <lb/>(±)-(3R,4S)-4-(3,5-Dimethoxyphenyl)-3-{[3-(4-ethoxyphenyl)ureido]methyl}-1-methylpyrrolidine-3-<lb/>carboxylic acid (14{3,6}): (From 6{3}) 1 H-NMR [300 MHz, δ (ppm), CD 3 SOCD 3 ]: 8.83 (bs, 1 1 H, <lb/>NHAr), 7.30-7.21 (m, 2 1 H, 2′′-CH + 6′′-CH), 6.79-6.70 (m, 2 1 H, 3′′-CH + 5′′-CH), 6.47 (d, J = 2.1 <lb/>Hz, 2 1 H, 2′-CH + 6′-CH), 6.41 (t, J = 2.1 Hz, 1 1 H, 4′-CH), 6.12 (bs, 1 1 H, CH 2 NH), 3.92 (q, J = 6.9 <lb/>Hz, 2 1 H, CH 2 CH 3 ), 3.72 (s, 6 1 H, 2 × OCH 3 ), 3.74-3.68 (m, 1 1 H, 4-CH), 3.45 (d, J = 10.2 Hz, 1 1 H, <lb/>2-CHH), 3.39 (dd; J = 9.6, 7.5 Hz; 1 1 H, 5-CHH), 3.24-3.18 (m, 1 1 H, 5-CHH), 3.17 (dd; J = 12.9, 8.1 <lb/>Hz; 1 1 H, CHHNH), 2.86 (d, J = 10.2 Hz, 1 1 H, 2-CHH), 2.64 (s, 3 1 H, NCH 3 ), 2.59 (dd; J = 12.9, 2.1 <lb/>Hz; 1 1 H, CHHNH), 1.28 (t, J = 6.9 Hz, 1 1 H, CH 2 CH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 176.7 <lb/>(CO 2 ), 160.2 (3′-C + 5′-C), 155.6 (NCON), 152.9 (4′′-C), 139.9 (1′-C), 133.9 (1′′-C), 119.0 (2′′-C + 6′′-<lb/>C), 114.4 (3′′-C + 5′′-C), 107.1 (2′-C + 6′-C), 98.3 (4′-C), 63.0 (CH 2 CH 3 ), 62.2 (2-C), 59.1 (5-C), 55.8 <lb/>(3-C), 55.1 (2 × OCH 3 ), 49.8 (4-C), 42.6 (NCH 3 ), 40.8 (CH 2 NH), 14.7 (CH 2 CH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), <lb/>neat]: 3354, 3250, 2947, 2836, 1671, 1594, 1542, 1204, 1153, 824. MS [APCI (m/z)] calcd for <lb/>(C 24 H 31 N 3 O 6 + H) + = 458, found 458. Crude yield: 52%. Purity: 99% (LC). <lb/>(±)-(3R,4S)-3-{[3-(3-Cyanophenyl)ureido]methyl}-4-(3,5-dimethoxyphenyl)-1-methylpyrrolidine-3-<lb/>carboxylic acid (14{3,7}): (From 6{3}) 1 H-NMR [300 MHz, δ (ppm), CD 3 SOCD 3 ]: 9.88 (bs, 1 1 H, <lb/>NHAr), 7.99 (s, 1 1 H, 2′-CH), 7.63 (d, J = 8.4 Hz, 1 1 H, 6′-CH), 7.38 (app t, J = 7.8 Hz, 1 1 H, 5′-CH), <lb/>7.28 (d, J = 7.5 Hz, 1 1 H, 4′-CH), 6.66 (bs, 1 1 H, CH 2 NH), 6.47 (d, J = 2.1 Hz, 2 1 H, 2′′-CH + 6′′-CH), <lb/>6.40 (t, J = 2.1 Hz, 1 1 H, 4′′-CH), 3.77 (app t, J = 8.7 Hz, 1 1 H, 4-CH), 3.71 (s, 6 1 H, 2 × OCH 3 ), 3.59 <lb/>(d, J = 10.5 Hz, 1 1 H, 2-CHH), 3.54 (dd; J = 9.9, 7.5 Hz; 1 1 H, 5-CHH), 3.37 (app t, J = 9.0 Hz, 1 1 H, <lb/>5-CHH), 3.23 (dd; J = 12.8, 8.4 Hz; 1 1 H, CHHNH), 2.97 (d, J = 10.5 Hz, 1 1 H, 2-CHH), 2.75 (s, 3 1 H, <lb/>NCH 3 ), 2.63 (dd; J = 12.8, 1.8 Hz; 1 1 H, CHHNH). 13 C-NMR [75 MHz, δ (ppm), CD 3 SOCD 3 ]: 176.7 <lb/>(CO 2 ), 160.2 (3′′-C + 5′′-C), 155.4 (NCON), 141.8 (1′-C), 139.3 (1′′-C), 129.9 (5′-C), 124.0 (4′-C), <lb/>122.0 (6′-C), 119.8 (2′-C), 119.1 (CN), 111.3 (3′-C), 107.0 (2′′-C + 6′′-C), 98.4 (4′′-C), 62.3 (2-C), 58.6 <lb/>(5-C), 55.9 (3-C), 55.1 (2 × OCH 3 ), 49.8 (4-C), 42.4 (NCH 3 ), 40.7 (CH 2 NH). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: <lb/>3377, 3184, 2942, 2838, 2790, 2234, 1679, 1594, 1543, 1203, 1150, 830. MS [APCI (m/z)] calcd for <lb/>(C 23 H 26 N 4 O 5 + H) + = 439, found 439. Crude yield: 58%. Purity: &gt;99% (LC). <lb/>(±)-(3R,4S)-4-(3,5-Dimethoxyphenyl)-1-methyl-3-{[3-(3-pyridyl)ureido]methyl}pyrrolidine-3-car-<lb/>boxylic acid (14{3,8}): (From 6{3}) MS [APCI (m/z)] calcd for (C 21 H 26 N 4 O 5 + H) + = 415, found 415. <lb/>Crude yield: 48%. Purity: 43% (LC). <lb/>(±)-(3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-methyl-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylic <lb/>acid (14{4,4}): (From 6{4}) 1 H-NMR [300 MHz, δ (ppm), CD 3 SOCD 3 ]: 9.01 (bs, 1 1 H, NHPh), 7.42-<lb/>7.34 (m, 2 1 H, 2′′-CH + 6′′-CH), 7.22-7.12 (m, 2 1 H, 3′′-CH + 5′′-CH), 6.96 (d, J = 1.2 Hz, 1 1 H, 4′-<lb/>CH), 6.86 (d, J = 8.1 Hz, 1 1 H, 7′-CH), 6.87-6.80 (m, 1 1 H, 4′′-CH), 6.76 (dd; J = 8.1, 1.2 Hz; 1 1 H, 6′-<lb/>CH), 6.26 (bd, J = 6.0 Hz, 1 1 H, CH 2 NH), 6.01-5.97 (m, 2 1 H, 2′-CH 2 ), 3.72 (app t, J = 8.2 Hz, 1 1 H, <lb/>4-CH), 3.46 (d, J = 10.5 Hz, 1 1 H, 2-CHH), 3.42 (dd; J = 9.9, 7.5 Hz; 1 1 H, 5-CHH), 3.25-3.17 (m, 1 <lb/>1 H, 5-CHH), 3.16 (dd; J = 12.9, 8.4 Hz; 1 1 H, CHHNH), 2.88 (d, J = 10.5 Hz, 1 1 H, 2-CHH), 2.65 (s, 3 <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2295 <lb/></page>

			<body>1 H, NCH 3 ), 2.58 (dd; J = 12.9, 2.4 Hz; 1 1 H, CHHNH). 13 C-NMR [75 MHz, δ (ppm), CD 3 SOCD 3 ]: <lb/>176.7 (CO 2 ), 155.4 (NCON), 147.1 (3′a-C), 146.1 (7′a-C), 140.8 (1′′-C), 131.3 (5′-C), 128.5 (3′′-C + <lb/>5′′-C), 121.9 (6′-C), 120.7 (4′′-C), 117.4 (2′′-C + 6′′-C), 108.9 (7′-C), 107.9 (4′-C), 100.9 (2′-C), 62.2 <lb/>(2-C), 59.4 (5-C), 55.9 (3-C), 49.5 (4-C), 42.8 (NCH 3 ), 40.5 (CH 2 NH). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3359, <lb/>3254, 2954, 2898, 2780, 1671, 1597, 1549, 1495, 1228, 1035, 931, 756, 694. MS [APCI (m/z)] calcd <lb/>for (C 21 H 23 N 3 O 5 + H) + = 398, found 398. Crude yield: 74%. Purity: &gt;99% (LC). <lb/>(±)-(3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-methyl-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)pyrrol-<lb/>idine-3-carboxylic acid (14{4,5}): (From 6{4}) FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3358, 3254, 2958, 2904, 1675, <lb/>1601, 1546, 1504, 1489, 1321, 1231, 1035, 931. MS [APCI (m/z)] calcd for (C 22 H 22 F 3 N 3 O 5 + H) + = <lb/>466, found 466. Crude yield: 68%. Purity: &gt;99% (LC). <lb/>(±)-(3R,4S)-4-(1,3-Benzodioxol-5-yl)-3-{[3-(4-ethoxyphenyl)ureido]methyl}-1-methylpyrrolidine-3-<lb/>carboxylic acid (14{4,6}): (From 6{4}) MS [APCI (m/z)] calcd for (C 23 H 27 N 3 O 6 + H) + = 442, found <lb/>442. Crude yield: 61%. Purity: 77% (LC). <lb/>(±)-(3R,4S)-4-(1,3-Benzodioxol-5-yl)-3-{[3-(3-cyanophenyl)ureido]methyl}-1-methylpyrrolidine-3-<lb/>carboxylic acid (14{4,7}): (From 6{4}) MS [APCI (m/z)] calcd for (C 22 H 22 N 4 O 5 + H) + = 423, found <lb/>423. Crude yield: 62%. Purity: 99% (LC). <lb/>(±)-(3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-methyl-3-{[3-(3-pyridyl)ureido]methyl}pyrrolidine-3-car-<lb/>boxylic acid (14{4,8}): (From 6{4}) MS [APCI (m/z)] calcd for (C 20 H 22 N 4 O 5 + H) + = 399, found 399. <lb/>Crude yield: 54%. Purity: 71% (LC). <lb/>(±)-(3R,4S)-1-Methyl-4-(1-methyl-1H-pyrrol-2-yl)-3-[(3-phenylureido)methyl]pyrrolidine-3-<lb/>carboxylic acid (14{5,4}): (From 6{5}) MS [APCI (m/z)] calcd for (C 19 H 24 N 4 O 3 + H) + = 357, found <lb/>357. Crude yield: 58%. Purity: 14% (LC). <lb/>(±)-(3R,4S)-1-Methyl-4-(1-methyl-1H-pyrrol-2-yl)-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)-<lb/>pyrrolidine-3-carboxylic acid (14{5,5}): (From 6{5}) MS [APCI (m/z)] calcd for (C 20 H 23 F 3 N 4 O 3 + <lb/>H) + = 425, found 425. Crude yield: 65%. Purity: 79% (LC). <lb/>(±)-(3R,4S)-3-{[3-(4-Ethoxyphenyl)ureido]methyl}-1-methyl-4-(1-methyl-1H-pyrrol-2-yl)pyrrolidine-<lb/>3-carboxylic acid (14{5,6}): (From 6{5}) MS [APCI (m/z)] calcd for (C 21 H 28 N 4 O 4 + H) + = 401, found <lb/>401. Crude yield: 62%. Purity: 16% (LC). <lb/>(±)-(3R,4S)-3-{[3-(3-Cyanophenyl)ureido]methyl}-1-methyl-4-(1-methyl-1H-pyrrol-2-yl)pyrrolidine-3-<lb/>carboxylic acid (14{5,7}): (From 6{5}) MS [APCI (m/z)] calcd for (C 20 H 23 N 5 O 3 + H) + = 382, found <lb/>382. Crude yield: 61%. Purity: 99% (LC). <lb/>(±)-(3R,4S)-1-Methyl-4-(1-methyl-1H-indol-3-yl)-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylic <lb/>acid (14{6,4}): (From 6{6}) MS [APCI (m/z)] calcd for (C 23 H 26 N 4 O 3 + H) + = 407, found 407. Crude <lb/>yield: 79%. Purity: 97% (LC). <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2296 <lb/></page>

			<body>(±)-(3R,4S)-1-Methyl-4-(1-methyl-1H-indol-3-yl)-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)-<lb/>pyrrolidine-3-carboxylic acid (14{6,5}): (From 6{6}) MS [APCI (m/z)] calcd for (C 24 H 25 F 3 N 4 O 3 + <lb/>H) + = 475, found 475. Crude yield: 76%. Purity: &gt;99% (LC). <lb/>(±)-(3R,4S)-3-{[3-(4-Ethoxyphenyl)ureido]methyl}-1-methyl-4-(1-methyl-1H-indol-3-yl)pyrrolidine-3-<lb/>carboxylic acid (14{6,6}): (From 6{6}) 1 H-NMR [400 MHz, δ (ppm), CD 3 SOCD 3 ]: 8.92 (bs, 1 1 H, <lb/>NHAr), 7.62 (d, J = 7.8 Hz, 1 1 H, 4′′-CH), 7.38 (d, J = 8.4 Hz, 1 1 H, 7′′-CH), 7.34 (s, 1 1 H, 2′′-CH), <lb/>7.29-7.21 (m, 2 1 H, 2′-CH + 6′-CH), 7.12 (app t, J = 7.5 Hz, 1 1 H, 6′′-CH), 6.96 (app t, J = 7.5 Hz, 1 <lb/>1 H, 5′′-CH), 6.77-6.69 (m, 2 1 H, 3′-CH + 5′-CH), 6.18 (bd, J = 6.9 Hz, 1 1 H, CH 2 NH), 4.11 (dd; <lb/>J = 9.6, 7.5 Hz; 1 1 H, 4-CH), 3.91 (q, J = 6.9 Hz, 2 1 H, CH 2 CH 3 ), 3.77 (s, 3 1 H, 1′′-NCH 3 ), 3.54 (d, <lb/>J = 10.2 Hz, 1 1 H, 2-CHH), 3.53-3.49 (m, 1 1 H, 5-CHH), 3.21 (dd; J = 13.2, 8.4 Hz; 1 1 H, CHHNH), <lb/>3.22-3.16 (m, 1 1 H, 5-CHH), 2.86 (d, J = 10.2 Hz, 1 1 H, 2-CHH), 2.68 (s, 3 1 H, 1-NCH 3 ), 2.66 (dd; <lb/>J = 13.2, 2.1 Hz; 1 1 H, CHHNH), 1.27 (t, J = 6.9 Hz, 3 1 H, CH 2 CH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3330, <lb/>2938, 2880, 1664, 1595, 1540, 827, 733. MS [APCI (m/z)] calcd for (C 25 H 30 N 4 O 4 + H) + = 451, found <lb/>451. Crude yield: 70%. Purity: 94% (LC). <lb/>(±)-(3R,4S)-3-{[3-(3-Cyanophenyl)ureido]methyl}-1-methyl-4-(1-methyl-1H-indol-3-yl)pyrrolidine-3-<lb/>carboxylic acid (14{6,7}): (From 6{6}) 1 H-NMR [400 MHz, δ (ppm), CD 3 SOCD 3 ]: 10.07 (bs, 1 1 H, <lb/>NHAr), 8.02 (s, 1 1 H, 2′-CH), 7.67 (d, J = 8.1 Hz, 1 1 H, 6′-CH), 7.61 (d, J = 7.8 Hz, 1 1 H, 4′′-CH), <lb/>7.39-7.36 (m, 1 1 H, 7′′-CH), 7.37 (app t, J = 7.8 Hz, 1 1 H, 5′-CH), 7.36 (s, 1 1 H, 2′′-CH), 7.27 (d, J = <lb/>7.5 Hz, 1 1 H, 4′-CH), 7.10 (app t, J = 7.5 Hz, 1 1 H, 6′′-CH), 6.88 (app t, J = 7.5 Hz, 1 1 H, 5′′-CH), 6.74 <lb/>(bs, 1 1 H, CH 2 NH), 4.17 (dd; J = 9.9, 7.8 Hz; 1 1 H, 4-CH), 3.77 (s, 3 1 H, 1′′-NCH 3 ), 3.73-3.63 (m, 2 <lb/>1 H, 2-CHH + 5-CHH), 3.36 (app t, J = 9.9 Hz, 1 1 H, 5-CHH), 3.29 (dd; J = 13.4, 9.0 Hz; 1 1 H, <lb/>CHHNH), 2.99 (d, J = 9.9 Hz, 1 1 H, 2-CHH), 2.80 (s, 3 1 H, 1-NCH 3 ), 2.68 (dd; J = 13.4, 2.1 Hz; 1 1 H, <lb/>CHHNH). 13 C-NMR [75 MHz, δ (ppm), CD 3 SOCD 3 ]: 177.3 (CO 2 ), 155.5 (NCON), 142.0 (1′-C), <lb/>136.6 (7′′a-C), 129.8 (5′-C), 127.7 (3′′a-C), 127.6 (2′′-C), 123.9 (4′-C), 122.0 (6′-C), 121.3 (6′′-C), <lb/>119.8 (2′-C), 119.4 (5′′-C), 119.1 (CN), 118.6 (4′′-C), 111.3 (3′-C), 109.6 (3′′-C), 109.3 (7′′-C), 62.6 <lb/>(2-C), 59.1 (5-C), 55.4 (3-C), 42.4 (1-NCH 3 ), 41.9 (4-C), 41.0 (CH 2 NH), 32.5 (1′′-NCH 3 ). FTIR [ <lb/>_ <lb/>ν <lb/>(cm -1 ), neat]: 3361, 2940, 2226, 1685, 1583, 1564, 742. MS [APCI (m/z)] calcd for (C 24 H 25 N 5 O 3 + H) + <lb/>= 432, found 432. Crude yield: 67%. Purity: 99% (LC). <lb/>(±)-(3R,4S)-1-Methyl-4-(1-methyl-1H-indol-3-yl)-3-{[3-(3-pyridyl)ureido]methyl}pyrrolidine-3-car-<lb/>boxylic acid (14{6,8}): (From 6{6}) MS [APCI (m/z)] calcd for (C 22 H 25 N 5 O 3 + H) + = 408, found 408. <lb/>Crude yield: 71%. Purity: 36% (LC). <lb/>(±)-Methyl (3R,4S)-1-methyl-4-phenyl-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylate (15{1,4}): <lb/>Phenyl isocyanate (2.563 g, 21.52 mmol) was added to a solution of α-aminomethyl ester 6{1} (4.858 <lb/>g, 19.56 mmol) in dry CH 2 Cl 2 (40 mL). The resulting reaction mixture was stirred at room temperature <lb/>for 2.5 h and the solvent was then evaporated to afford 15{1,4} (6.895 g, 96%) as a white foam, after <lb/>column chromatography (CH 2 Cl 2 /MeOH, 14:1). 1 H-NMR [300 MHz, δ (ppm), CDCl 3 ]: 7.47 (bs, 1 1 H, <lb/>NHPh), 7.28-7.15 (m, 9 1 H, Ph′ + 2′′-CH + 3′′-CH + 5′′-CH + 6′′-CH), 7.03-6.96 (m, 1 1 H, 4′′-CH), <lb/>5.35 (bdd; J = 7.8, 3.6 Hz; 1 1 H, CH 2 NH), 3.91 (app t, J = 8.2 Hz, 1 1 H, 4-CH), 3.70 (s, 3 1 H, OCH 3 ), <lb/>3.44 (dd; J = 14.1, 8.4 Hz; 1 1 H, CHHNH), 3.20 (d, J = 9.6 Hz, 1 1 H, 2-CHH), 3.05 (app t, J = 8.6 Hz, <lb/></body>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2297 <lb/></page>

			<body>1 1 H, 5-CHH), 2.96 (app t, J = 9.0 Hz, 1 1 H, 5-CHH), 2.80 (dd; J = 14.1, 3.9 Hz; 1 1 H, CHHNH), 2.72 <lb/>(d, J = 9.6 Hz, 1 1 H, 2-CHH), 2.39 (s, 3 1 H, NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 176.0 <lb/>(CO 2 ), 156.1 (NCON), 138.8 (1′′-C), 137.3 (1′-C), 129.0 (2′-C + 6′-C)*, 128.5 (3′-C + 5′-C)*, 128.4 <lb/>(3′′-C + 5′′-C)*, 127.2 (4′-C), 123.2 (4′′-C), 120.5 (2′′-C + 6′′-C), 63.3 (2-C), 60.4 (5-C), 57.0 (3-C), <lb/>52.8 (OCH 3 ), 50.8 (4-C), 44.0 (CH 2 NH), 42.3 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3323, 2952, 2836, 2790, <lb/>1725, 1656, 1597, 1554, 751, 701. HRMS [ESI (m/z)] calcd for (C 21 H 25 N 3 O 3 + H) + = 368.19687, <lb/>found 368.19803 (|Δ| = 1.7 ppm). R F : 0.40 (CH 2 Cl 2 /MeOH, 8:1). Mp: 160.6 °C. <lb/>(±)-(4R,5S)-2-Methyl-4,7-diphenyl-2,7,9-triazaspiro[4.5]decane-6,8-dione (5{1,4}): A 1 M solution of <lb/>KOBu t in THF (120 μL, 120 μmol) was added to a solution of α-ureido ester 15{1,4} (44 mg, 120 <lb/>μmol) in THF (4 mL). The resulting reaction mixture was stirred for 55 min at 31 °C. Brine (1 mL) <lb/>was then added. The layers were separated and the aqueous phase was extracted with CH 2 Cl 2 (2 × 1.5 <lb/>mL). The combined organic layers were dried over Na 2 SO 4 and concentrated in vacuo. The residue <lb/>afforded 5{1,4} (23 mg, 57%) as a white solid, after column chromatography (CH 2 Cl 2 /MeOH, 19:1). <lb/>1 H-NMR [300 MHz, δ (ppm), CD 3 SOCD 3 ]: 7.79 (bd, J = 3.0 Hz, 1 1 H, NH), 7.43-7.20 (m, 8 1 H, Ph′ + <lb/>3′′-CH + 4′′-CH + 5′′-CH), 7.16-7.11 (m, 2 1 H, 2′′-CH + 6′′-CH), 4.05 (app t, J = 6.9 Hz, 1 1 H, 4-CH), <lb/>2.98 (dd; J = 9.0, 6.6 Hz; 1 1 H, 3-CHH), 2.95-2.84 (m, 4 1 H, 1-CH 2 + 3-CHH + 10-CHH), 2.67 (dd; <lb/>J = 12.6, 1.5 Hz; 1 1 H, 10-CHH), 2.36 (s, 3 1 H, NCH 3 ). 13 C-NMR [75 MHz, δ (ppm), CDCl 3 ]: 173.3 <lb/>(6-C), 153.9 (8-C), 139.0 (1′-C), 135.4 (1′′-C), 129.1 (3′′-C + 5′′-C), 128.63 (3′-C + 5′-C)*, 128.58 (2′′-<lb/>C + 6′′-C)*, 128.5 (2′-C + 6′-C)*, 128.4 (4′′-C), 127.2 (4′-C), 64.0 (1-C), 62.0 (3-C), 52.5 (5-C), 48.3 <lb/>(4-C), 43.7 (10-C), 42.1 (NCH 3 ). FTIR [ <lb/>_ <lb/>ν (cm -1 ), neat]: 3254, 2945, 2835, 2792, 1725, 1684, 767, <lb/>753, 707, 693. Elem. anal. calcd for C 20 H 21 N 3 O 2 : C 71.62%, H 6.31%, N 12.53%; found C 71.70%, H <lb/>6.17%, N 12.48%. R F : 0.44 (CH 2 Cl 2 /MeOH, 8:1). Mp: 231.5 °C (from MeOH, colorless crystals). <lb/>Purity: &gt;99.5% (GC). <lb/>5. Conclusions <lb/>In summary, we have developed a general high-yielding method for the synthesis of trans-4-aryl-<lb/>substituted 3-(aminomethyl)pyrrolidine-3-carboxylates. We have shown that these aryl groups can be <lb/>phenyl or electron-rich aryls (4-methoxyphenyl, 3,5-dimethoxyphenyl, and 1,3-benzodioxol-5-yl) and <lb/>electron-rich heteroaryls (1-methylpyrrol-2-yl and 1-methylindol-3-yl). As a result, we anticipate that <lb/>this methodology can be successfully applied for a wide range of aromatic groups, although with <lb/>electron-poor heteroaryls (2-, 3-, and 4-pyridyl) mixtures of cis-trans isomers are formed after the <lb/>cycloaddition step. <lb/>We have also developed a method for the synthesis of a small library of 7-alkyldihydrouracils spiro-<lb/>fused to pyrrolidines to the 3-position. The corresponding 7-aryl derivatives hydrolyzed under the <lb/>conditions utilized for the cyclization and yielded α-ureidomethyl acids. The optimization of this <lb/>cyclization should be further developed. <lb/></body>

			<div type="acknowledgement">Acknowledgements <lb/>We would like to thank Richard H. Blaauw and Chiralix B.V. (Nijmegen, The Netherlands) for the <lb/>use of their parallel-synthesis facilities. This work was financially supported by the Council of <lb/></div>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2298 <lb/></page>

			<div type="annex">Chemical Sciences of The Netherlands Organization for Scientific Research (NWO), MSD Research <lb/>Laboratories (former N.V. Organon; Oss, The Netherlands), and Solvay Pharmaceuticals (Weesp, The <lb/>Netherlands). <lb/></div>

			<listBibl>References and Notes <lb/>1. Von Bohlen und Halbach, O.; Dermietzel, R. Neurotransmitters and Neuromodulators: Handbook <lb/>of Receptors and Biological Effects, 2nd ed.; Wiley-VCH: Weinheim, Germany, 2006. <lb/>2. Campbell, L.M. From Adrenaline to Formoterol: Advances in β-Agonist Therapy in the <lb/>Treatment of Asthma. Int. J. Clin. Pract. 2002, 56, 783-790. <lb/>3. Skidmore, I.F.; Lunts, L.H.C.; Finch, H.; Naylor, A. Phenethanolamin-Verbindungen, Verfahren <lb/>zu Ihrer Herstellung und Diese Verbindungen Enthaltende Arzneimittel. DE 3414752, October 18, <lb/>1984; [Chem. Abstr. 1985, 102, 95383]. <lb/>4. Johnson, D.S.; Li, J.J. The Art of Drug Synthesis; John Wiley &amp; Sons: Hoboken, NJ, USA, 2007. <lb/>5. Yardley, J.P.; Husbands, G.E.M.; Stack, G.; Butch, J.; Bisckler, J.; Moyer, J.A.; Muth, E.A.; <lb/>Andree, T.; Fletcher, H., III; James, M.N.G.; Sieleck, A.R. 2-Phenyl-2-(1-hydroxy-<lb/>cycloalkyl)ethylamine Derivatives: Synthesis and Antidepressant Activity. J. Med. Chem. 1990, <lb/>33, 2899-2905. <lb/>6. Husbands, G.E.M.; Yardley, J.P.; Muth, E.A. 2-Phenyl-2-(1-hydroxycycloalkyl or 1-<lb/>hydroxycycloalk-2-enyl)ethylamine Derivatives. US 4535186, August 13, 1985; [Chem. Abstr. <lb/>1985, 102, 5895]. <lb/>7. Carlucci, D.R.; Aitken, M. IMS Intelligence 360, 2007. IMS Health Home Page. <lb/>http://www.imshealth.com/ims/portal/front/articleC/0,2777,6266_41382706_81567488,00.html/ <lb/>(accessed Jun 20, 2009). <lb/>8. Shulgin, A.; Shulgin, A. Pihkal: A Chemical Love Story; Transform Press: Berkeley, CA, USA, <lb/>1991. <lb/>9. Shulgin, A.; Shulgin, A. Tihkal: The Continuation; Transform Press: Berkeley, CA, USA, 1997. <lb/>10. Nelson, D.L.; Cox, M.M. Nucleotides and Nucleic Acids. In Lehninger Principles of <lb/>Biochemistry, 4th ed.; W. H. Freeman: New York, NY, USA, 2004; pp. 273-305. <lb/>11. Lowe, J.A., III; Archer, R.L.; Chapin, D.S.; Cheng, J.B.; Helweg, D.; Johnson, J.L.; Koe, B.K.; <lb/>Lebel, L.A.; Moore, P.F.; Nielsen, J.A.; Russo, L.L.; Shirley, J.T. Structure-Activity Relationship <lb/>of Quinazolinedione Inhibitors of Calcium-Independent Phosphodiesterase. J. Med. Chem. 1991, <lb/>34, 624-628. <lb/>12. Shimazaki, N.; Yamazaki, H.; Yatabe, T.; Tanaka, H. Quinazoline Derivatives and Their <lb/>Preparation. EP 0481342, April 22, 1992; [Chem. Abstr. 1992, 117, 131217]. <lb/>13. Mignani, S.; Damour, D.; Doble, A.; Labaudinière, R.; Malleron, J.-L.; Plot, O.; Gueremy, C. <lb/>New Indole Derivatives as Potent and Selective Serotonin Uptake Inhibitors. Bioorg. Med. Chem. <lb/>Lett. 1993, 3, 1913-1918. <lb/>14. Jones, K.A.; Weaver, D.F.; Tiedje, K.E. Dihydrouracil Compounds as Anti-Ictogenic or Anti-<lb/>Epileptogenic Agents. WO 2004009559, January 29, 2004; [Chem. Abstr. 2004, 140, 146155]. <lb/>15. Mitsuya, H.; Yarchoan, R.; Broder, S. Molecular Targets for AIDS Therapy. Science 1990, 249, <lb/>1533-1544. <lb/></listBibl>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2299 <lb/></page>

			<listBibl>16. Ishii, T.; Motoyoshi, M.; Jiyatsukesu, B. Uracil Compound and Fungicide. JP 63290867, <lb/>November 28, 1988; [Chem. Abstr. 1988, 111, 153828]. <lb/>17. Wright, T.R.; Fuerst, E.P.; Ogg, A.G., Jr.; Nandihalli, U.B.; Lee, H.J. Herbicidal Activity of <lb/>UCC-C4243 and Acifluorfen is Due to Inhibition of Protophyrinogen Oxidase. Weed Sci. 1995, <lb/>43, 47-54. <lb/>18. Boger, D.L.; Labroli, M.A.; Marsilje, T.H.; Jin, Q.; Hedrick, M.P.; Baker, S.J.; Shim, J.H.; <lb/>Benkovic, S.J. Conformationally Restricted Analogues Designed for Selective Inhibition of GAR <lb/>Tfase versus Thymidylate Synthase or Dihydrofolate Reductase. Bioorg. Med. Chem. 2000, 8, <lb/>1075-1086. <lb/>19. Hruby, V.J. Conformational Restrictions of Biologically Active Peptides via Amino Acid Side <lb/>Chain Groups. Life Sci. 1982, 31, 189-199. <lb/>20. Charton, J.; Gassiot, A.C.; Girault-Mizzi, S.; Debreu-Fontaine, M.A.; Melnyk, P.; Sergheraert, C. <lb/>Synthesis and Pharmacological Evaluation of Tic-Hydantoin Derivatives as Selective σ1 Ligands. <lb/>Part 1. Bioorg. Med. Chem. Lett. 2005, 15, 4833-4837. <lb/>21. Hotha, S.; Yarrow, J.C.; Yang, J.G.; Garrett, S.; Renduchintala, K.V.; Mayer, T.U.; Kapoor, T.M. <lb/>HR22C16: a Potent Small-Molecule Probe for the Dynamics of Cell Division. Angew. Chem. Int. <lb/>Ed. 2003, 42, 2379-2382. <lb/>22. Tietze, L.F.; Beifuss, U. The Knoevenagel Reaction. In Comprehensive Organic Synthesis; Trost, <lb/>B. M., Fleming, I., Eds.; Pergamon Press: Oxford, England, UK, 1991; Volume 2, pp. 341-394. <lb/>23. Maadi, A.E.; Matthiesen, C.L.; Ershadi, P.; Baker, J.; Herron, D.M.; Holt, E.M. Knoevenagel <lb/>Condensation Catalyzed by K 2 NiP 2 O 7 . Synthesis of (E)-Methyl α-Cyanocinnamates in High <lb/>Yields. J. Chem. Cryst. 2003, 33, 757-763. <lb/>24. Kingsbury, C.A.; Draney, D.; Sopchik, A.; Rissler, W.; Durham, D. Survey of Carbon-13-<lb/>Hydrogen Splittings in Alkenes. J. Org. Chem. 1976, 41, 3863-3868. <lb/>25. Hayashi, T. Studies on Geometric Isomerism by Nuclear Magnetic Resonance. III. <lb/>Stereochemistry of α-Cyanocinnamic Esters1. J. Org. Chem. 1966, 31, 3253-3258. <lb/>26. Huisgen, R. In 1,3-Dipolar Cycloaddition Chemistry; Padwa, A., Ed.; Wiley-Interscience: New <lb/>York, NY, USA, 1984; Volume 1, pp. 1-176. <lb/>27. Coldham, I.; Hufton, R. Intramolecular Dipolar Cycloaddition Reactions of Azomethine Ylides. <lb/>Chem. Rev. 2005, 105, 2765-2809. <lb/>28. Snider, B.B.; Ahn, Y.; O&apos;Hare, S.M. Total Synthesis of (±)-Martinellic Acid. Org. Lett. 2001, 3, <lb/>4217-4220. <lb/>29. Pandey, G.; Lakshmaiah, G. Ag(I)F as One Electron Oxidant for Promoting Sequential Double <lb/>Desilylation: An Ideal Approach to Non-Stabilized Azomethine Ylides for the Rapid Construction <lb/>of 1-Azabicyclo (m:3:0) Alkanes. Tetrahedron Lett. 1993, 34, 4861-4864. <lb/>30. Pandey, G.; Lakshmaiah, G.; Kumaraswamy, G. A New and Efficient Strategy for Non-Stabilized <lb/>Azomethine Ylide via Photoinduced Electron Transfer (PET) Initiated Sequential Double <lb/>Desilylation. J. Chem. Soc., Chem. Commun. 1992, 1313-1314. <lb/>31. Deprez, P.; Royer, J.; Husson, H.P. Synthesis of Highly Functionalized 3-(3-Pyridyl)pyrrolidine <lb/>and 3-(3-Pyridyl)pyrroles. Synthesis 1991, 759-762. <lb/>32. Padwa, A.; Dent, W. Use of N-[(Trimethylsilyl)methyl]amino Ethers as Capped Azomethine <lb/>Ylide Equivalents. J. Org. Chem. 1987, 52, 235-244. <lb/></listBibl>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2300 <lb/></page>

			<listBibl>33. Tsuge, O.; Kanemasa, S.; Takenaka, S. Stereoselective Synthesis of Hexa-and <lb/>Tetrahydroindolizin-7-ones Through Cycloaddition Pyridinium Methylides. J. Org. Chem. 1986, <lb/>51, 1853-1855. <lb/>34. Confalone, P.N.; Earl, R.A. Intramolecular (3+2) Cycloadditions of Functionalized Azomethine <lb/>Ylides. Tetrahedron Lett. 1986, 27, 2695-2698. <lb/>35. Grigg, R.; Gunaratne, H.Q.N.; Kemp, J. X=Y-ZH Systems as Potential 1,3-Dipoles. Part 1. <lb/>Background and Scope. J. Chem. Soc. Perkin Trans. 1 1984, 41-46. <lb/>36. Padwa, A.; Chen, Y.-Y. Synthesis of Pyrrolidines Using an α-Cyanoaminosilane as an <lb/>Azomethine Ylide Equivalent. Tetrahedron Lett. 1983, 24, 3447-3450. <lb/>37. Beugelmans, R.; Negron, G.; Roussi, G. Trimethylamine N-Oxide as a Precursor of Azomethine <lb/>Ylides. J. Chem. Soc., Chem. Commun. 1983, 31-32. <lb/>38. Grigg, R.; Gunaratne, H.Q.N. Brönsted and Lewis Acid Catalysis of X=Y-ZH Cycloadditions. J. <lb/>Chem. Soc., Chem. Commun. 1982, 384-386. <lb/>39. Vedejs, E.; Martinez, G.R. Methylides from Trimethylsilylmethylsulfonium, -Ammonium, <lb/>-Immonium, and Phosphonium Salts. J. Am. Chem. Soc. 1979, 101, 6452-6454. <lb/>40. Rizzi, G.P. Elimination of Methyl Mercaptan from N-Substituted N′-Cyano-S-Methylisothioureas. <lb/>Evidence for N-Cyanocarbodiimides. J. Org. Chem. 1970, 35, 2069-2072. <lb/>41. Lown, J.W.; Smalley, R.K.; Dallas, G. The Addition of Azomethine Ylids to <lb/>Diphenylcyclopropenone: Synthesis of Novel 4-Oxazolines. J. Chem. Soc., Chem. Commun. <lb/>1968, 1543-1545. <lb/>42. Blanco-Ania, D.; Hermkens, P.H.H.; Sliedregt, L.A.J.M.; Scheeren, H.W.; Rutjes, F.P.J.T. <lb/>Synthesis of Cucurbitine Derivatives: Facile Straightforward Approach to Methyl 3-Amino-4-<lb/>aryl-1-methylpyrrolydine-3-carboxylates. Tetrahedron 2009, 65, 5393-5401. <lb/>43. Huisgen, R.; Mloston, G.; Langhals, E. The First Two-Step 1,3-Dipolar Cycloadditions: Non-<lb/>Stereospecificity. J. Am. Chem. Soc. 1986, 108, 6401-6402. <lb/>44. Allan, G.; Carnell, A.J.; Escudero Hernandez, M.L.; Pettman, A. Chemoenzymatic Synthesis of a <lb/>Tachykinin NK-2 Antagonist. Tetrahedron 2001, 57, 8193-8202. <lb/>45. Avenoza, A.; Cativiela, C.; París, M.; Peregrina, J.M. Synthesis of a New Type of <lb/>Conformationally Constrained α,α-Disubstituted-β-amino Acids and β-Lactams in <lb/>Enantiomerically Pure Form. Tetrahedron Asymmetry 1995, 6, 1409-1418. <lb/>46. Patiño-Molina, R.; Cubero-Lajo, I.; Pérez-de Vega, M.J.; García-López, M.T.; González-Muñiz, <lb/>R. Chiral 1,3,6-Trisubstituted 2,4-Dioxohexahydropyrimidines: a Convenient Stereoselective <lb/>Synthesis from Aspartic Acid Derivatives. Tetrahedron Lett. 2007, 48, 3613-3616. <lb/>47. Blanco-Ania, D.; Hermkens, P.H.H.; Sliedregt, L.A.J.M.; Scheeren, H.W.; Rutjes, F.P.J.T. <lb/>Synthesis of Hydantoins and Thiohydantoins Spiro-Fused to Pyrrolidines: Druglike Molecules <lb/>Based on the 2-Arylethyl Amine Scaffold. J. Comb. Chem. 2009, 11, 527-538. <lb/>48. Kantminienė, K.; Beresnevičius, Z.; Mikulskienė, G.; Kihlberg, J.; Broddefalk, J. Alkylation of 1-<lb/>(3,4-Disubstituted Phenyl)-2-thioxo-1,2,5,6-tetrahydropyrimidin-4(3H)-ones. J. Chem. Res. (S) <lb/>1999, 16-17. <lb/>49. Gyónfalvi, S.; Szakonyi, Z.; Fülöp, F. Syntesis and Transformation of Novel Cyclic β-Amino <lb/>Acid Derivatives from (+)-3-Carene. Tetrahedron Asymmetry 2003, 14, 3965-3972. <lb/></listBibl>

			<note place="headnote">Molecules 2010, 15 <lb/></note>

			<page>2301 <lb/></page>

			<listBibl>50. Szakonyi, Z.; Martinek, T.; Hetényi, A.; Fülöp, F. Regio-and Stereoselective Synthesis of the <lb/>Enantiomers of Monoterpene-Based β-Amino Acid Derivatives. Tetrahedron Asymmetry 2000, <lb/>11, 4571-4579. <lb/>51. Gong, Y.-D.; Najdi, S.; Olmstead, M.M.; Kurth, M.J. Solid-Phase Synthesis: Intramolecular <lb/>Azomethine Ylide Cycloaddition (→Proline) and Carbanilide Cyclization (→Hydantoin) <lb/>Reactions. J. Org. Chem. 1998, 63, 3081-3086. <lb/>52. Herrero, S.; Salgado, A.; García-López, M.T.; Herranz, R. Versatile Synthesis of Chiral 2-<lb/>Substituted-5-oxo-1,2,3,4-tetrahydro-5H-1,4-benzodiazepines <lb/>as <lb/>Novel <lb/>Scaffolds <lb/>for <lb/>Peptidomimetic Building. Tetrahedron Lett. 2002, 43, 4899-4902. <lb/>53. Tewari, N.; Mishra, R.C.; Tiwari, V.K.; Tripathi, R.P. DBU Catalyzed Cyclative Amidation <lb/>Reaction: A Convenient Syntesis of C-Nucleoside Analogs. Synlett 2002, 1779-1782. <lb/>54. Murata, T.; Sugawara, T.; Ukawa, K. A New Synthesis of β-Aminopyrroles and Related <lb/>Heterocycles. Chem. Pharm. Bull. 1978, 26, 3080-3100. <lb/>55. Peláez, W.J.; Szakonyi, Z.; Fülöp, F.; Yranzo, G.I. Flash Vacuum Pyrolysis (fvp) of Some <lb/>Hexahydroquinazolin-4(1H)-ones. Tetrahedron 2008, 64, 1049-1057. <lb/>56. Vaickelioniene, R.; Mickevicius, V.; Mikulskiene, G. Synthesis and Cyclizations of N-(2,3-, 3,4-<lb/>and 3,5-Dimethylphenyl)-β-alanines. Molecules 2005, 10, 407-416. <lb/>57. Kolodziej, S.A.; Hamper, B.C. Solid-Phase Synthesis of 5,6-Dihydropyrimidine-2,4-diones. <lb/>Tetrahedron Lett. 1996, 37, 5277-5280. <lb/>58. Rachina, V.; Blagoeva, I.B.; Pojarlieff, I.G.; Yates, K. β-Ureido Acids and Dihydrouracils. The <lb/>Kinetics and Mechanism of the Reversible Ring Closure of 3-(3′-Methy1ureido)-propanoic Acid <lb/>and 3-(3 1 -Phenylureido)-2-methylpropanoic Acid in Sulfuric Acid Solutions. Can. J. Chem. 1990, <lb/>68, 1676-1684. <lb/>59. Gottlieb, H.E.; Kotlyar, V.; Nudelman, A. NMR Chemical Shifts of Common Laboratory Solvents <lb/>as Trace Impurities. J. Org. Chem. 1997, 62, 7512-7515. <lb/></listBibl>

			<front>Sample Availability: Contact the authors. <lb/>© 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. <lb/>This article is an open-access article distributed under the terms and conditions of the Creative <lb/>Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). </front>


	</text>
</tei>